These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|||||||||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
Title of each class | Trading Symbols |
Name of each exchange
on which registered |
||||||
|
|
|
||||||
|
|
|
||||||
|
|
|
||||||
|
|
|
||||||
|
|
|
|
☒ | Accelerated filer | ☐ | ||||||||
Non-accelerated filer | ☐ | Smaller reporting company |
|
||||||||
Emerging growth company |
|
Part I Financial Information
|
Page
|
|||||||
Item 1. Financial Statements (unaudited) as of September 30, 2023 and December 31, 2022 and for the Three Month and Nine Month Periods Ended September 30, 2023 and 2022 | ||||||||
Property-Liability
Operations
|
||||||||
Segment results | ||||||||
Part II Other Information | ||||||||
(In millions, except per share data) |
Three months ended
September 30, |
Nine months ended September 30, | ||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||
Property and casualty insurance premiums | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Accident and health insurance premiums and contract charges |
|
|
|
|
||||||||||||||||||||||
Other revenue |
|
|
|
|
||||||||||||||||||||||
Net investment income |
|
|
|
|
||||||||||||||||||||||
Net gains (losses) on investments and derivatives |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Total revenues |
|
|
|
|
||||||||||||||||||||||
Costs and expenses | ||||||||||||||||||||||||||
Property and casualty insurance claims and claims expense |
|
|
|
|
||||||||||||||||||||||
Accident, health and other policy benefits (including remeasurement (gains) losses of $
|
|
|
|
|
||||||||||||||||||||||
Amortization of deferred policy acquisition costs |
|
|
|
|
||||||||||||||||||||||
Operating costs and expenses |
|
|
|
|
||||||||||||||||||||||
Pension and other postretirement remeasurement (gains) losses |
|
|
|
|
||||||||||||||||||||||
Restructuring and related charges |
|
|
|
|
||||||||||||||||||||||
Amortization of purchased intangibles |
|
|
|
|
||||||||||||||||||||||
Interest expense |
|
|
|
|
||||||||||||||||||||||
Total costs and expenses |
|
|
|
|
||||||||||||||||||||||
Loss from operations before income tax expense |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Income tax benefit |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Net loss |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interest |
|
(
|
(
|
(
|
||||||||||||||||||||||
Net loss attributable to Allstate |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Less: Preferred stock dividends |
|
|
|
|
||||||||||||||||||||||
Net loss applicable to common shareholders | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Earnings per common share: | ||||||||||||||||||||||||||
Net loss applicable to common shareholders per common share - Basic | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Weighted average common shares - Basic |
|
|
|
|
||||||||||||||||||||||
Net loss applicable to common shareholders per common share - Diluted | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Weighted average common shares - Diluted |
|
|
|
|
||||||||||||||||||||||
($ in millions) | Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Net loss | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Other comprehensive loss, after-tax | ||||||||||||||||||||||||||
Changes in: | ||||||||||||||||||||||||||
Unrealized net capital gains and losses |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Unrealized foreign currency translation adjustments |
(
|
(
|
|
(
|
||||||||||||||||||||||
Unamortized pension and other postretirement prior service credit |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Discount rate for reserve for future policy benefits
|
|
|
|
|
||||||||||||||||||||||
Other comprehensive loss, after-tax |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Comprehensive loss |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Less: Comprehensive loss attributable to noncontrolling interest |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Comprehensive loss attributable to Allstate | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
($ in millions, except par value data) | September 30, 2023 | December 31, 2022 | ||||||||||||
Assets | ||||||||||||||
Investments | ||||||||||||||
Fixed income securities, at fair value (amortized cost, net $
|
$ |
|
$ |
|
||||||||||
Equity securities, at fair value (cost $
|
|
|
||||||||||||
Mortgage loans, net |
|
|
||||||||||||
Limited partnership interests |
|
|
||||||||||||
Short-term, at fair value (amortized cost $
|
|
|
||||||||||||
Other investments, net |
|
|
||||||||||||
Total investments |
|
|
||||||||||||
Cash |
|
|
||||||||||||
Premium installment receivables, net |
|
|
||||||||||||
Deferred policy acquisition costs |
|
|
||||||||||||
Reinsurance and indemnification recoverables, net |
|
|
||||||||||||
Accrued investment income |
|
|
||||||||||||
Deferred income taxes |
|
|
||||||||||||
Property and equipment, net |
|
|
||||||||||||
Goodwill |
|
|
||||||||||||
Other assets, net |
|
|
||||||||||||
Total assets |
|
|
||||||||||||
Liabilities | ||||||||||||||
Reserve for property and casualty insurance claims and claims expense |
|
|
||||||||||||
Reserve for future policy benefits |
|
|
||||||||||||
Contractholder funds |
|
|
||||||||||||
Unearned premiums |
|
|
||||||||||||
Claim payments outstanding |
|
|
||||||||||||
Other liabilities and accrued expenses |
|
|
||||||||||||
Debt |
|
|
||||||||||||
Total liabilities |
|
|
||||||||||||
Commitments and Contingent Liabilities (Note 14)
|
|
|
||||||||||||
Equity | ||||||||||||||
Preferred stock and additional capital paid-in, $
|
|
|
||||||||||||
Common stock, $
|
|
|
||||||||||||
Additional capital paid-in |
|
|
||||||||||||
Retained income |
|
|
||||||||||||
Treasury stock, at cost (
|
(
|
(
|
||||||||||||
Accumulated other comprehensive income (loss): | ||||||||||||||
Unrealized net capital gains and losses |
(
|
(
|
||||||||||||
Unrealized foreign currency translation adjustments |
(
|
(
|
||||||||||||
Unamortized pension and other postretirement prior service credit |
|
|
||||||||||||
Discount rate for reserve for future policy benefits
|
|
(
|
||||||||||||
Total accumulated other comprehensive loss |
(
|
(
|
||||||||||||
Total Allstate shareholders’ equity |
|
|
||||||||||||
Noncontrolling interest |
(
|
(
|
||||||||||||
Total equity |
|
|
||||||||||||
Total liabilities and equity | $ |
|
$ |
|
($ in millions, except per share data) | Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Preferred stock par value | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Preferred stock additional capital paid-in | ||||||||||||||||||||||||||
Balance, beginning of period |
|
|
|
|
||||||||||||||||||||||
Preferred stock issuance, net of issuance costs |
|
|
|
|
||||||||||||||||||||||
Preferred stock redemption |
|
|
(
|
|
||||||||||||||||||||||
Balance, end of period |
|
|
|
|
||||||||||||||||||||||
Common stock par value |
|
|
|
|
||||||||||||||||||||||
Common stock additional capital paid-in | ||||||||||||||||||||||||||
Balance, beginning of period |
|
|
|
|
||||||||||||||||||||||
Equity incentive plans activity, net
|
|
|
|
|
||||||||||||||||||||||
Balance, end of period |
|
|
|
|
||||||||||||||||||||||
Retained income | ||||||||||||||||||||||||||
Balance, beginning of period |
|
|
|
|
||||||||||||||||||||||
Net loss |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Dividends on common stock (declared per share of $
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Dividends on preferred stock |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Balance, end of period |
|
|
|
|
||||||||||||||||||||||
Treasury stock | ||||||||||||||||||||||||||
Balance, beginning of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Shares acquired |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Shares reissued under equity incentive plans, net |
|
|
|
|
||||||||||||||||||||||
Balance, end of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Accumulated other comprehensive income (loss) | ||||||||||||||||||||||||||
Balance, beginning of period |
(
|
(
|
(
|
|
||||||||||||||||||||||
Change in unrealized net capital gains and losses |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Change in unrealized foreign currency translation adjustments |
(
|
(
|
|
(
|
||||||||||||||||||||||
Change in unamortized pension and other postretirement prior service credit |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Change in discount rate for reserve for future policy benefits
|
|
|
|
|
||||||||||||||||||||||
Balance, end of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Total Allstate shareholders’ equity |
|
|
|
|
||||||||||||||||||||||
Noncontrolling interest | ||||||||||||||||||||||||||
Balance, beginning of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Change in unrealized net capital gains and losses |
(
|
(
|
|
(
|
||||||||||||||||||||||
Noncontrolling income (loss) |
|
(
|
(
|
(
|
||||||||||||||||||||||
Balance, end of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Total equity | $ |
|
$ |
|
$ |
|
$ |
|
($ in millions) | Nine months ended September 30, | |||||||||||||
2023 | 2022 | |||||||||||||
Cash flows from operating activities | ||||||||||||||
Net loss | $ |
(
|
$ |
(
|
||||||||||
Adjustments to reconcile net loss to net cash provided by operating activities: | ||||||||||||||
Depreciation, amortization and other non-cash items |
|
|
||||||||||||
Net (gains) losses on investments and derivatives |
|
|
||||||||||||
Pension and other postretirement remeasurement (gains) losses |
|
|
||||||||||||
Changes in: | ||||||||||||||
Policy benefits and other insurance reserves |
|
|
||||||||||||
Unearned premiums |
|
|
||||||||||||
Deferred policy acquisition costs |
(
|
(
|
||||||||||||
Premium installment receivables, net |
(
|
(
|
||||||||||||
Reinsurance recoverables, net |
|
|
||||||||||||
Income taxes |
(
|
(
|
||||||||||||
Other operating assets and liabilities |
(
|
(
|
||||||||||||
Net cash provided by operating activities |
|
|
||||||||||||
Cash flows from investing activities | ||||||||||||||
Proceeds from sales | ||||||||||||||
Fixed income securities |
|
|
||||||||||||
Equity securities |
|
|
||||||||||||
Limited partnership interests |
|
|
||||||||||||
Other investments |
|
|
||||||||||||
Investment collections | ||||||||||||||
Fixed income securities |
|
|
||||||||||||
Mortgage loans |
|
|
||||||||||||
Other investments |
|
|
||||||||||||
Investment purchases | ||||||||||||||
Fixed income securities |
(
|
(
|
||||||||||||
Equity securities |
(
|
(
|
||||||||||||
Limited partnership interests |
(
|
(
|
||||||||||||
Mortgage loans |
(
|
(
|
||||||||||||
Other investments |
(
|
(
|
||||||||||||
Change in short-term and other investments, net |
|
|
||||||||||||
Purchases of property and equipment, net |
(
|
(
|
||||||||||||
Proceeds from sale of property and equipment |
|
|
||||||||||||
Net cash used in investing activities |
(
|
(
|
||||||||||||
Cash flows from financing activities | ||||||||||||||
Proceeds from issuance of debt |
|
|
||||||||||||
Repayment of debt |
(
|
|
||||||||||||
Proceeds from issuance of preferred stock |
|
|
||||||||||||
Redemption of preferred stock |
(
|
|
||||||||||||
Contractholder fund deposits |
|
|
||||||||||||
Contractholder fund withdrawals |
(
|
(
|
||||||||||||
Dividends paid on common stock |
(
|
(
|
||||||||||||
Dividends paid on preferred stock |
(
|
(
|
||||||||||||
Treasury stock purchases |
(
|
(
|
||||||||||||
Shares reissued under equity incentive plans, net |
|
|
||||||||||||
Other |
|
(
|
||||||||||||
Net cash used in financing activities |
(
|
(
|
||||||||||||
Net increase in cash |
|
|
||||||||||||
Cash at beginning of period |
|
|
||||||||||||
Cash at end of period | $ |
|
$ |
|
Note 1 | General |
After-tax cumulative effect of change in accounting principle on transition date
|
||||||||||||||||||||
($ in millions) | January 1, 2021 | |||||||||||||||||||
Decrease in retained income | $ |
|
||||||||||||||||||
Decrease in accumulated other comprehensive income (“AOCI”) |
|
|||||||||||||||||||
Total decrease in equity | $ |
|
Impact of adoption for reserve for future policy benefits
|
||||||||||||||||||||
($ in millions)
|
Accident and health | Traditional life | Total | |||||||||||||||||
Pre-adoption 12/31/2020 balance
(1)
|
$ |
|
$ |
|
$ |
|
||||||||||||||
Adjustments: | ||||||||||||||||||||
Effect of the remeasurement of the reserve at upper-medium grade fixed income-based rate
(2)
|
|
|
|
|||||||||||||||||
Adjustments for contracts with net premiums in excess of gross premiums
(3)
|
|
|
|
|||||||||||||||||
Total adjustments |
|
|
|
|||||||||||||||||
Post-adoption 1/1/2021 balance |
|
|
|
|||||||||||||||||
Less: reinsurance recoverables
(4)
|
|
|
|
|||||||||||||||||
Post-adoption 1/1/2021 balance, after reinsurance recoverables | $ |
|
$ |
|
$ |
|
Impact of adoption for DAC | ||||||||||||||||||||||||||
($ in millions)
|
Accident and health | Traditional life | Interest- sensitive life | Total | ||||||||||||||||||||||
Pre-adoption 12/31/2020 balance | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Adjustment for removal of impact of unrealized gains or losses
(1)
|
|
|
|
|
||||||||||||||||||||||
Post-adoption 1/1/2021 balance | $ |
|
$ |
|
$ |
|
$ |
|
Condensed Consolidated Statements of Operations | ||||||||||||||||||||
As
reported |
Impact of change |
As
adjusted |
||||||||||||||||||
($ in millions, except per share data) | Three months ended September 30, 2022 | |||||||||||||||||||
Revenues | ||||||||||||||||||||
Accident and health insurance premiums and contract charges | $ |
|
$ |
|
$ |
|
||||||||||||||
Total revenues |
|
|
|
|||||||||||||||||
Costs and expenses | ||||||||||||||||||||
Accident, health and other policy benefits |
|
(
|
|
|||||||||||||||||
Amortization of deferred policy acquisition costs |
|
|
|
|||||||||||||||||
Total costs and expenses |
|
(
|
|
|||||||||||||||||
Loss from operations before income tax expense |
(
|
|
(
|
|||||||||||||||||
Income tax benefit |
(
|
|
(
|
|||||||||||||||||
Net loss |
(
|
|
(
|
|||||||||||||||||
Net loss attributable to Allstate |
(
|
|
(
|
|||||||||||||||||
Net loss applicable to common shareholders | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
Earnings per common share: | ||||||||||||||||||||
Net loss applicable to common shareholders per common share - Basic | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
Net loss applicable to common shareholders per common share - Diluted | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
Nine months ended September 30, 2022 | ||||||||||||||||||||
Revenues | ||||||||||||||||||||
Accident and health insurance premiums and contract charges | $ |
|
$ |
(
|
$ |
|
||||||||||||||
Total revenues |
|
(
|
|
|||||||||||||||||
Costs and expenses | ||||||||||||||||||||
Accident, health and other policy benefits |
|
(
|
|
|||||||||||||||||
Amortization of deferred policy acquisition costs |
|
(
|
|
|||||||||||||||||
Total costs and expenses |
|
(
|
|
|||||||||||||||||
Loss from operations before income tax expense |
(
|
|
(
|
|||||||||||||||||
Income tax benefit |
(
|
|
(
|
|||||||||||||||||
Net loss |
(
|
|
(
|
|||||||||||||||||
Net loss attributable to Allstate |
(
|
|
(
|
|||||||||||||||||
Net loss applicable to common shareholders | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
Earnings per common share: | ||||||||||||||||||||
Net loss applicable to common shareholders per common share - Basic | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
Net loss applicable to common shareholders per common share - Diluted | $ |
(
|
$ |
|
$ |
(
|
Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited)
|
||||||||||||||||||||
As reported | Impact of change | As adjusted | ||||||||||||||||||
($ in millions) | Three months ended September 30, 2022 | |||||||||||||||||||
Net loss | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
Other comprehensive loss, after-tax | ||||||||||||||||||||
Changes in: | ||||||||||||||||||||
Unrealized net capital gains and losses |
(
|
|
(
|
|||||||||||||||||
Discount rate for reserve for future policy benefits
|
|
|
|
|||||||||||||||||
Other comprehensive loss, after-tax
|
(
|
|
(
|
|||||||||||||||||
Comprehensive loss |
(
|
|
(
|
|||||||||||||||||
Comprehensive loss attributable to Allstate | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
Nine months ended September 30, 2022 | ||||||||||||||||||||
Net loss | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
Other comprehensive loss, after-tax | ||||||||||||||||||||
Changes in: | ||||||||||||||||||||
Unrealized net capital gains and losses |
(
|
(
|
(
|
|||||||||||||||||
Discount rate for reserve for future policy benefits
|
|
|
|
|||||||||||||||||
Other comprehensive loss, after-tax
|
(
|
|
(
|
|||||||||||||||||
Comprehensive loss |
(
|
|
(
|
|||||||||||||||||
Comprehensive loss attributable to Allstate | $ |
(
|
$ |
|
$ |
(
|
Condensed Consolidated Statements of Financial Position (unaudited) | ||||||||||||||||||||
As
reported |
Impact of change |
As
adjusted |
||||||||||||||||||
($ in millions) | December 31, 2022 | |||||||||||||||||||
Assets | ||||||||||||||||||||
Deferred policy acquisition costs | $ |
|
$ |
|
$ |
|
||||||||||||||
Reinsurance and indemnification recoverables, net |
|
|
|
|||||||||||||||||
Deferred income taxes |
|
(
|
|
|||||||||||||||||
Other assets, net |
|
(
|
|
|||||||||||||||||
Total assets |
|
|
|
|||||||||||||||||
Liabilities | ||||||||||||||||||||
Reserve for future policy benefits |
|
|
|
|||||||||||||||||
Contractholder funds |
|
(
|
|
|||||||||||||||||
Unearned premiums |
|
(
|
|
|||||||||||||||||
Total liabilities |
|
|
|
|||||||||||||||||
Equity | ||||||||||||||||||||
Retained income |
|
|
|
|||||||||||||||||
Accumulated other comprehensive income (loss): | ||||||||||||||||||||
Unrealized net capital gains and losses |
(
|
(
|
(
|
|||||||||||||||||
Discount rate for reserve for future policy benefits
|
|
(
|
(
|
|||||||||||||||||
Total AOCI |
(
|
(
|
(
|
|||||||||||||||||
Total Allstate shareholders’ equity |
|
|
|
|||||||||||||||||
Total equity |
|
|
|
|||||||||||||||||
Total liabilities and equity | $ |
|
$ |
|
$ |
|
Condensed Consolidated Statements of Shareholders’ Equity (unaudited) | ||||||||||||||||||||
As
reported |
Impact of change |
As
adjusted |
||||||||||||||||||
($ in millions) | Three months ended September 30, 2022 | |||||||||||||||||||
Retained income | ||||||||||||||||||||
Balance, beginning of period | $ |
|
$ |
|
$ |
|
||||||||||||||
Net loss |
(
|
|
(
|
|||||||||||||||||
Balance, end of period |
|
|
|
|||||||||||||||||
Accumulated other comprehensive income (loss) | ||||||||||||||||||||
Balance, beginning of period |
(
|
(
|
(
|
|||||||||||||||||
Change in unrealized net capital gains and losses |
(
|
|
(
|
|||||||||||||||||
Change in discount rate for reserve for future policy benefits
|
|
|
|
|||||||||||||||||
Balance, end of period |
(
|
|
(
|
|||||||||||||||||
Total Allstate shareholders’ equity |
|
|
|
|||||||||||||||||
Total equity | $ |
|
$ |
|
$ |
|
||||||||||||||
Nine months ended September 30, 2022 | ||||||||||||||||||||
Retained income | ||||||||||||||||||||
Balance, beginning of period | $ |
|
$ |
(
|
$ |
|
||||||||||||||
Net loss |
(
|
|
(
|
|||||||||||||||||
Balance, end of period |
|
|
|
|||||||||||||||||
Accumulated other comprehensive income (loss) | ||||||||||||||||||||
Balance, beginning of period |
|
(
|
|
|||||||||||||||||
Change in unrealized net capital gains and losses |
(
|
(
|
(
|
|||||||||||||||||
Change in discount rate for reserve for future policy benefits
|
|
|
|
|||||||||||||||||
Balance, end of period |
(
|
|
(
|
|||||||||||||||||
Total Allstate shareholders’ equity |
|
|
|
|||||||||||||||||
Total equity | $ |
|
$ |
|
$ |
|
Condensed Consolidated Statements of Cash Flows (unaudited) | ||||||||||||||||||||
As
reported |
Impact of change |
As
adjusted |
||||||||||||||||||
($ in millions) | Nine months ended September 30, 2022 | |||||||||||||||||||
Cash flows from operating activities | ||||||||||||||||||||
Net loss | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||||||||||||||
Changes in: | ||||||||||||||||||||
Policy benefits and other insurance reserves |
|
(
|
|
|||||||||||||||||
Unearned premiums |
|
(
|
|
|||||||||||||||||
Deferred policy acquisition costs |
(
|
(
|
(
|
|||||||||||||||||
Reinsurance recoverables, net |
|
|
|
|||||||||||||||||
Income taxes |
(
|
|
(
|
|||||||||||||||||
Other operating assets and liabilities |
(
|
|
(
|
|||||||||||||||||
Net cash provided by operating activities | $ |
|
$ |
|
$ |
|
Note 2 | Earnings per Common Share |
Computation of basic and diluted earnings per common share
|
||||||||||||||||||||||||||
(In millions, except per share data) | Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Numerator:
|
|
|
|
|
||||||||||||||||||||||
Net loss | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interest |
|
(
|
(
|
(
|
||||||||||||||||||||||
Net loss attributable to Allstate |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Less: Preferred stock dividends
|
|
|
|
|
||||||||||||||||||||||
Net loss applicable to common shareholders | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Denominator:
|
|
|
|
|||||||||||||||||||||||
Weighted average common shares outstanding
|
|
|
|
|
||||||||||||||||||||||
Effect of dilutive potential common shares
(1)
:
|
|
|
||||||||||||||||||||||||
Stock options
|
|
|
|
|
||||||||||||||||||||||
Restricted stock units (non-participating) and performance stock awards
|
|
|
|
|
||||||||||||||||||||||
Weighted average common and dilutive potential common shares outstanding
|
|
|
|
|
||||||||||||||||||||||
Earnings per common share - Basic | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Earnings per common share - Diluted
(1)
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Anti-dilutive options excluded from diluted earnings per common share
|
|
|
|
|
||||||||||||||||||||||
Weighted average dilutive potential common shares excluded due to net loss applicable to common shareholders
(1)
|
|
|
|
|
Note 3 | Reportable Segments |
• | Net gains and losses on investments and derivatives | ||||
• | Pension and other postretirement remeasurement gains and losses | ||||
• | Amortization or impairment of purchased intangibles | ||||
• | Gain or loss on disposition | ||||
• | Adjustments for other significant non-recurring, infrequent or unusual items, when (a) the nature of the charge or gain is such that it is reasonably unlikely to recur within two years, or (b) there has been no similar charge or gain within the prior two years | ||||
• | Income tax expense or benefit on reconciling items |
Reportable segments financial performance
|
||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Underwriting income (loss) by segment | ||||||||||||||||||||||||||
Allstate Protection | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Run-off Property-Liability
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Total Property-Liability |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Adjusted net income (loss) by segment, after-tax | ||||||||||||||||||||||||||
Protection Services |
|
|
|
|
||||||||||||||||||||||
Allstate Health and Benefits
|
|
|
|
|
||||||||||||||||||||||
Corporate and Other |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Reconciling items | ||||||||||||||||||||||||||
Property-Liability net investment income |
|
|
|
|
||||||||||||||||||||||
Net gains (losses) on investments and derivatives |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Pension and other postretirement remeasurement gains (losses) |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Amortization of purchased intangibles
(1)
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Gain (loss) on disposition |
(
|
(
|
(
|
|
||||||||||||||||||||||
Non-recurring costs
(2)
|
|
|
(
|
|
||||||||||||||||||||||
Income tax benefit on reconciling items |
|
|
|
|
||||||||||||||||||||||
Total reconciling items |
|
|
|
|
||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interest
(3)
|
|
(
|
(
|
(
|
||||||||||||||||||||||
Net loss applicable to common shareholders | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
Reportable segments revenue information
|
||||||||||||||||||||||||||
($ in millions) | Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Property-Liability | ||||||||||||||||||||||||||
Insurance premiums | ||||||||||||||||||||||||||
Auto | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Homeowners |
|
|
|
|
||||||||||||||||||||||
Other personal lines |
|
|
|
|
||||||||||||||||||||||
Commercial lines |
|
|
|
|
||||||||||||||||||||||
Other business lines |
|
|
|
|
||||||||||||||||||||||
Allstate Protection |
|
|
|
|
||||||||||||||||||||||
Run-off Property-Liability
|
|
|
|
|
||||||||||||||||||||||
Total Property-Liability insurance premiums |
|
|
|
|
||||||||||||||||||||||
Other revenue |
|
|
|
|
||||||||||||||||||||||
Net investment income |
|
|
|
|
||||||||||||||||||||||
Net gains (losses) on investments and derivatives |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Total Property-Liability |
|
|
|
|
||||||||||||||||||||||
Protection Services | ||||||||||||||||||||||||||
Protection plans |
|
|
|
|
||||||||||||||||||||||
Roadside assistance |
|
|
|
|
||||||||||||||||||||||
Finance and insurance products |
|
|
|
|
||||||||||||||||||||||
Intersegment premiums and service fees
(1)
|
|
|
|
|
||||||||||||||||||||||
Other revenue |
|
|
|
|
||||||||||||||||||||||
Net investment income |
|
|
|
|
||||||||||||||||||||||
Net gains (losses) on investments and derivatives |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Total Protection Services |
|
|
|
|
||||||||||||||||||||||
Allstate Health and Benefits
|
||||||||||||||||||||||||||
Employer voluntary benefits |
|
|
|
|
||||||||||||||||||||||
Group health |
|
|
|
|
||||||||||||||||||||||
Individual health |
|
|
|
|
||||||||||||||||||||||
Other revenue |
|
|
|
|
||||||||||||||||||||||
Net investment income |
|
|
|
|
||||||||||||||||||||||
Net gains (losses) on investments and derivatives |
(
|
(
|
|
(
|
||||||||||||||||||||||
Total Allstate Health and Benefits
|
|
|
|
|
||||||||||||||||||||||
Corporate and Other | ||||||||||||||||||||||||||
Other revenue |
|
|
|
|
||||||||||||||||||||||
Net investment income |
|
|
|
|
||||||||||||||||||||||
Net gains (losses) on investments and derivatives |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Total Corporate and Other |
|
|
|
|
||||||||||||||||||||||
Intersegment eliminations
(1)
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Consolidated revenues | $ |
|
$ |
|
$ |
|
$ |
|
Note 4 | Investments |
Portfolio composition
|
||||||||||||||
($ in millions) | September 30, 2023 | December 31, 2022 | ||||||||||||
Fixed income securities, at fair value | $ |
|
$ |
|
||||||||||
Equity securities, at fair value |
|
|
||||||||||||
Mortgage loans, net |
|
|
||||||||||||
Limited partnership interests |
|
|
||||||||||||
Short-term investments, at fair value |
|
|
||||||||||||
Other investments, net |
|
|
||||||||||||
Total | $ |
|
$ |
|
Amortized cost, gross unrealized gains (losses) and fair value for fixed income securities
|
||||||||||||||||||||||||||
($ in millions) | Amortized cost, net | Gross unrealized |
Fair
value
|
|||||||||||||||||||||||
Gains | Losses | |||||||||||||||||||||||||
September 30, 2023 | ||||||||||||||||||||||||||
U.S. government and agencies | $ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||
Municipal |
|
|
(
|
|
||||||||||||||||||||||
Corporate |
|
|
(
|
|
||||||||||||||||||||||
Foreign government |
|
|
(
|
|
||||||||||||||||||||||
ABS |
|
|
(
|
|
||||||||||||||||||||||
Total fixed income securities | $ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||
December 31, 2022 | ||||||||||||||||||||||||||
U.S. government and agencies | $ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||
Municipal |
|
|
(
|
|
||||||||||||||||||||||
Corporate |
|
|
(
|
|
||||||||||||||||||||||
Foreign government |
|
|
(
|
|
||||||||||||||||||||||
ABS |
|
|
(
|
|
||||||||||||||||||||||
Total fixed income securities | $ |
|
$ |
|
$ |
(
|
$ |
|
Scheduled maturities for fixed income securities
|
|||||||||||||||||||||||||||||
($ in millions) | September 30, 2023 | December 31, 2022 | |||||||||||||||||||||||||||
Amortized cost, net |
Fair
value
|
Amortized cost, net |
Fair
value
|
||||||||||||||||||||||||||
Due in one year or less | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
Due after one year through five years |
|
|
|
|
|||||||||||||||||||||||||
Due after five years through ten years |
|
|
|
|
|||||||||||||||||||||||||
Due after ten years |
|
|
|
|
|||||||||||||||||||||||||
|
|
|
|
||||||||||||||||||||||||||
ABS |
|
|
|
|
|||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
Net investment income
|
||||||||||||||||||||||||||
($ in millions) | Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Fixed income securities | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Equity securities |
|
|
|
|
||||||||||||||||||||||
Mortgage loans |
|
|
|
|
||||||||||||||||||||||
Limited partnership interests |
|
|
|
|
||||||||||||||||||||||
Short-term investments |
|
|
|
|
||||||||||||||||||||||
Other investments |
|
|
|
|
||||||||||||||||||||||
Investment income, before expense |
|
|
|
|
||||||||||||||||||||||
Investment expense |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Net investment income
|
$ |
|
$ |
|
$ |
|
$ |
|
Net gains (losses) on investments and derivatives by asset type
|
||||||||||||||||||||||||||
($ in millions) | Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Fixed income securities | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Equity securities |
(
|
(
|
|
(
|
||||||||||||||||||||||
Mortgage loans |
(
|
|
(
|
|
||||||||||||||||||||||
Limited partnership interests |
(
|
(
|
|
(
|
||||||||||||||||||||||
Derivatives |
|
|
(
|
|
||||||||||||||||||||||
Other investments |
|
(
|
|
|
||||||||||||||||||||||
Net gains (losses) on investments and derivatives | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
Net gains (losses) on investments and derivatives by transaction type
|
||||||||||||||||||||||||||
($ in millions)
|
Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Sales | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Credit losses |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Valuation change of equity investments
(1)
|
(
|
(
|
|
(
|
||||||||||||||||||||||
Valuation change and settlements of derivatives |
|
|
(
|
|
||||||||||||||||||||||
Net gains (losses) on investments and derivatives | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
Gross realized gains (losses) on sales of fixed income securities | ||||||||||||||||||||||||||
($ in millions) | Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Gross realized gains | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Gross realized losses |
(
|
(
|
(
|
(
|
Net appreciation (decline) recognized in net income for assets that are still held | ||||||||||||||||||||||||||
($ in millions) | Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Equity securities | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
Limited partnership interests carried at fair value
|
|
(
|
|
|
||||||||||||||||||||||
Total | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
Credit losses recognized in net income | ||||||||||||||||||||||||||
($ in millions) | Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||
Fixed income securities: | ||||||||||||||||||||||||||
Corporate | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
ABS |
|
(
|
|
(
|
||||||||||||||||||||||
Total fixed income securities |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Mortgage loans |
(
|
|
(
|
|
||||||||||||||||||||||
Limited partnership interests |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Other investments | ||||||||||||||||||||||||||
Bank loans |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Total credit losses by asset type | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Liabilities | ||||||||||||||||||||||||||
Commitments to fund commercial mortgage loans and bank loans |
(
|
|
(
|
|
||||||||||||||||||||||
Total | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
Unrealized net capital gains and losses included in AOCI | ||||||||||||||||||||||||||
($ in millions) |
Fair
value
|
Gross unrealized |
Unrealized net
gains (losses)
|
|||||||||||||||||||||||
September 30, 2023 | Gains | Losses | ||||||||||||||||||||||||
Fixed income securities | $ |
|
$ |
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Short-term investments |
|
|
(
|
(
|
||||||||||||||||||||||
Derivative instruments |
|
|
(
|
(
|
||||||||||||||||||||||
Limited partnership interests
(1)
|
(
|
|||||||||||||||||||||||||
Unrealized net capital gains and losses, pre-tax |
(
|
|||||||||||||||||||||||||
Reclassification of noncontrolling interest |
|
|||||||||||||||||||||||||
Deferred income taxes |
|
|||||||||||||||||||||||||
Unrealized net capital gains and losses, after-tax | $ |
(
|
||||||||||||||||||||||||
December 31, 2022 | ||||||||||||||||||||||||||
Fixed income securities | $ |
|
$ |
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Short-term investments |
|
|
(
|
(
|
||||||||||||||||||||||
Derivative instruments |
|
|
(
|
(
|
||||||||||||||||||||||
Limited partnership interests
(1)
|
|
|
|
|
||||||||||||||||||||||
Unrealized net capital gains and losses, pre-tax |
(
|
|||||||||||||||||||||||||
Reclassification of noncontrolling interest |
|
|||||||||||||||||||||||||
Deferred income taxes |
|
|||||||||||||||||||||||||
Unrealized net capital gains and losses, after-tax | $ |
(
|
Change in unrealized net capital gains (losses)
|
||||||||||||||||||||||||||||||||||||||
($ in millions) | Nine months ended September 30, 2023 | |||||||||||||||||||||||||||||||||||||
Fixed income securities | $ |
(
|
||||||||||||||||||||||||||||||||||||
Short-term investments |
|
|||||||||||||||||||||||||||||||||||||
Derivative instruments |
|
|||||||||||||||||||||||||||||||||||||
Limited partnership interests |
(
|
|||||||||||||||||||||||||||||||||||||
Total |
(
|
|||||||||||||||||||||||||||||||||||||
Reclassification of noncontrolling interest |
(
|
|||||||||||||||||||||||||||||||||||||
Deferred income taxes |
|
|||||||||||||||||||||||||||||||||||||
Decrease in unrealized net capital gains and losses, after-tax | $ |
(
|
Carrying value for limited partnership interests
|
||||||||||||||||||||||||||||||||||||||
($ in millions) | September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||||||||||||||||
EMA | Fair Value | Total | EMA | Fair Value | Total | |||||||||||||||||||||||||||||||||
Private equity | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||
Real estate |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Other
(1)
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
Other investments by asset type | ||||||||||||||
($ in millions) | September 30, 2023 | December 31, 2022 | ||||||||||||
Bank loans, net | $ |
|
$ |
|
||||||||||
Real estate |
|
|
||||||||||||
Policy loans |
|
|
||||||||||||
Derivatives |
|
|
||||||||||||
Other |
|
|
||||||||||||
Total | $ |
|
$ |
|
Rollforward of credit loss allowance for fixed income securities
|
||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Beginning balance | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Credit losses on securities for which credit losses not previously reported |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Net (increases) decreases related to credit losses previously reported |
|
(
|
(
|
(
|
||||||||||||||||||||||
(Increase) decrease of allowance related to sales and other
|
(
|
|
(
|
|
||||||||||||||||||||||
Write-offs |
|
|
|
|
||||||||||||||||||||||
Ending balance | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Components of credit loss allowance as of September 30
|
||||||||||||||||||||||||||
Corporate bonds | $ |
(
|
$ |
(
|
||||||||||||||||||||||
ABS |
(
|
(
|
||||||||||||||||||||||||
Total | $ |
(
|
$ |
(
|
Gross unrealized losses and fair value by type and length of time held in a continuous unrealized loss position
(1)
|
||||||||||||||||||||||||||||||||||||||||||||
($ in millions) | Less than 12 months | 12 months or more |
Total
unrealized
losses
|
|||||||||||||||||||||||||||||||||||||||||
Number
of
issues
|
Fair
value
|
Unrealized
losses
|
Number
of
issues
|
Fair
value
|
Unrealized
losses
|
|||||||||||||||||||||||||||||||||||||||
September 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||
Fixed income securities | ||||||||||||||||||||||||||||||||||||||||||||
U.S. government and agencies |
|
$ |
|
$ |
(
|
|
$ |
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||||||||||
Municipal |
|
|
(
|
|
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||
Corporate |
|
|
(
|
|
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||
Foreign government |
|
|
(
|
|
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||
ABS |
|
|
|
|
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||
Total fixed income securities |
|
$ |
|
$ |
(
|
|
$ |
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||||||||||
Investment grade fixed income securities |
|
$ |
|
$ |
(
|
|
$ |
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||||||||||
Below investment grade fixed income securities |
|
|
(
|
|
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||
Total fixed income securities |
|
$ |
|
$ |
(
|
|
$ |
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||||||||||
December 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||
Fixed income securities | ||||||||||||||||||||||||||||||||||||||||||||
U.S. government and agencies |
|
$ |
|
$ |
(
|
|
$ |
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||||||||||
Municipal |
|
|
(
|
|
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||
Corporate |
|
|
(
|
|
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||
Foreign government |
|
|
(
|
|
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||
ABS |
|
|
(
|
|
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||
Total fixed income securities |
|
$ |
|
$ |
(
|
|
$ |
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||||||||||
Investment grade fixed income securities |
|
$ |
|
$ |
(
|
|
$ |
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||||||||||
Below investment grade fixed income securities |
|
|
(
|
|
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||
Total fixed income securities |
|
$ |
|
$ |
(
|
|
$ |
|
$ |
(
|
$ |
(
|
Gross unrealized losses by unrealized loss position and credit quality as of September 30, 2023 | ||||||||||||||||||||
($ in millions) |
Investment
grade
|
Below investment grade | Total | |||||||||||||||||
Fixed income securities with unrealized loss position less than 20% of amortized cost, net
(1) (2)
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||
Fixed income securities with unrealized loss position greater than or equal to 20% of amortized cost, net
(3) (4)
|
(
|
(
|
(
|
|||||||||||||||||
Total unrealized losses | $ |
(
|
$ |
(
|
$ |
(
|
Accrued interest
|
||||||||||||||
($ in millions) | September 30, | December 31, | ||||||||||||
2023 | 2022 | |||||||||||||
Mortgage loans | $ |
|
$ |
|
||||||||||
Bank Loans |
|
|
Mortgage loans amortized cost by debt service coverage ratio distribution and year of origination
|
||||||||||||||||||||||||||||||||||||||||||||||||||
September 30, 2023 | December 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||
($ in millions) | 2018 and prior | 2019 | 2020 | 2021 | 2022 | Current | Total | Total | ||||||||||||||||||||||||||||||||||||||||||
Below 1.0 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||
1.0 - 1.25 |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
1.26 - 1.50 |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Above 1.50 |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Amortized cost before allowance | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||
Allowance |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||
Amortized cost, net | $ |
|
$ |
|
Rollforward of credit loss allowance for mortgage loans
|
||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Beginning balance | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Net (increases) decreases related to credit losses |
(
|
|
(
|
|
||||||||||||||||||||||
Write-offs |
|
|
|
|
||||||||||||||||||||||
Ending balance
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Bank loans amortized cost by credit rating and year of origination
|
||||||||||||||||||||||||||||||||||||||||||||||||||
September 30, 2023 | December 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||
($ in millions) | 2018 and prior | 2019 | 2020 | 2021 | 2022 | Current | Total | Total | ||||||||||||||||||||||||||||||||||||||||||
NAIC 2 / BBB | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||
NAIC 3 / BB |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
NAIC 4 / B |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
NAIC 5-6 / CCC and below |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Amortized cost before allowance | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||
Allowance |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||
Amortized cost, net | $ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||||||
Rollforward of credit loss allowance for bank loans
|
||||||||||||||||||||||||||
($ in millions) | Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Beginning balance | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Net increases related to credit losses |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Reduction of allowance related to sales |
|
|
|
|
||||||||||||||||||||||
Write-offs |
|
|
|
|
||||||||||||||||||||||
Ending balance
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
Note 5 | Fair Value of Assets and Liabilities |
Assets and liabilities measured at fair value
|
||||||||||||||||||||||||||||||||
September 30, 2023 | ||||||||||||||||||||||||||||||||
($ in millions) | Quoted prices in active markets for identical assets (Level 1) | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | Counterparty and cash collateral netting | Total | |||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||||||||
Fixed income securities: | ||||||||||||||||||||||||||||||||
U.S. government and agencies | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||
Municipal |
|
|
|
|
||||||||||||||||||||||||||||
Corporate - public |
|
|
|
|
||||||||||||||||||||||||||||
Corporate - privately placed |
|
|
|
|
||||||||||||||||||||||||||||
Foreign government |
|
|
|
|
||||||||||||||||||||||||||||
ABS |
|
|
|
|
||||||||||||||||||||||||||||
Total fixed income securities |
|
|
|
|
||||||||||||||||||||||||||||
Equity securities |
|
|
|
|
|
|||||||||||||||||||||||||||
Short-term investments |
|
|
|
|
||||||||||||||||||||||||||||
Other investments |
|
|
|
$ |
(
|
|
||||||||||||||||||||||||||
Other assets |
|
|
|
|
||||||||||||||||||||||||||||
Total recurring basis assets |
|
|
|
(
|
|
|||||||||||||||||||||||||||
Non-recurring basis
|
|
|
|
|
||||||||||||||||||||||||||||
Total assets at fair value | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||
% of total assets at fair value |
|
% |
|
% |
|
% |
|
% |
|
% | ||||||||||||||||||||||
Investments reported at NAV |
|
|||||||||||||||||||||||||||||||
Total | $ |
|
||||||||||||||||||||||||||||||
Liabilities | ||||||||||||||||||||||||||||||||
Other liabilities | $ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||||||
Total recurring basis liabilities |
(
|
(
|
|
|
(
|
|||||||||||||||||||||||||||
Total liabilities at fair value | $ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||||||
% of total liabilities at fair value |
|
% |
|
% |
|
% |
(
|
% |
|
% |
Assets and liabilities measured at fair value | ||||||||||||||||||||||||||||||||
December 31, 2022 | ||||||||||||||||||||||||||||||||
($ in millions) | Quoted prices in active markets for identical assets (Level 1) | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | Counterparty and cash collateral netting | Total | |||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||||||||
Fixed income securities: | ||||||||||||||||||||||||||||||||
U.S. government and agencies | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||
Municipal |
|
|
|
|
||||||||||||||||||||||||||||
Corporate - public |
|
|
|
|
||||||||||||||||||||||||||||
Corporate - privately placed |
|
|
|
|
||||||||||||||||||||||||||||
Foreign government |
|
|
|
|
||||||||||||||||||||||||||||
ABS |
|
|
|
|
||||||||||||||||||||||||||||
Total fixed income securities |
|
|
|
|
||||||||||||||||||||||||||||
Equity securities |
|
|
|
|
|
|||||||||||||||||||||||||||
Short-term investments |
|
|
|
|
|
|||||||||||||||||||||||||||
Other investments |
|
|
|
$ |
(
|
|
||||||||||||||||||||||||||
Other assets |
|
|
|
|
||||||||||||||||||||||||||||
Total recurring basis assets |
|
|
|
(
|
|
|||||||||||||||||||||||||||
Non-recurring basis |
|
|
|
|
||||||||||||||||||||||||||||
Total assets at fair value | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||
% of total assets at fair value |
|
% |
|
% |
|
% |
|
% |
|
% | ||||||||||||||||||||||
Investments reported at NAV |
|
|||||||||||||||||||||||||||||||
Total | $ |
|
||||||||||||||||||||||||||||||
Liabilities | ||||||||||||||||||||||||||||||||
Other liabilities | $ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||||||
Total recurring basis liabilities |
(
|
(
|
|
|
(
|
|||||||||||||||||||||||||||
Total liabilities at fair value | $ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||||||
% of total liabilities at fair value |
|
% |
|
% |
|
% |
(
|
% |
|
% |
Rollforward of Level 3 assets and liabilities held at fair value during the three month period ended September 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance as of
June 30, 2023 |
Total gains (losses)
included in: |
Transfers |
Balance as of
September 30, 2023 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
($ in millions) | Net income | OCI | Into Level 3 | Out of Level 3 | Purchases | Sales | Issues | Settlements | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed income securities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Municipal | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||||||||
Corporate - public |
|
|
(
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate - privately placed |
|
|
(
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ABS |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total fixed income securities |
|
|
(
|
|
|
|
(
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity securities |
|
|
|
|
|
|
(
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Short-term investments |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other investments |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other assets |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total recurring Level 3 assets | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||||||||
Rollforward of Level 3 assets and liabilities held at fair value during the nine month period ended September 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance as of December 31, 2022 |
Total gains (losses)
included in: |
Transfers | Balance as of September 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
($ in millions) | Net income | OCI | Into Level 3 | Out of Level 3 | Purchases | Sales | Issues | Settlements | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed income securities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Municipal | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||||||||
Corporate - public |
|
(
|
|
|
|
|
(
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate - privately placed |
|
(
|
|
|
|
|
(
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ABS |
|
|
|
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total fixed income securities |
|
(
|
|
|
|
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity securities |
|
|
|
|
|
|
(
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Short-term investments |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other investments |
|
(
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other assets |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total recurring Level 3 assets | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||||||||
Rollforward of Level 3 assets and liabilities held at fair value during the three month period ended September 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance as of
June 30, 2022 |
Total gains (losses)
included in: |
Transfers |
Balance as of
September 30, 2022 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
($ in millions) | Net income | OCI | Into Level 3 | Out of Level 3 | Purchases | Sales | Issues | Settlements | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed income securities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Municipal | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
Corporate - public |
|
|
(
|
|
|
|
(
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate - privately placed |
|
|
|
|
|
|
(
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
ABS |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total fixed income securities |
|
|
(
|
|
(
|
|
(
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity securities |
|
(
|
|
|
|
|
(
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Short-term investments |
|
|
|
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Other investments |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Other assets |
|
(
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total recurring Level 3 assets | $ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
Rollforward of Level 3 assets and liabilities held at fair value during the nine month period ended September 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance as of
December 31, 2021 |
Total gains (losses)
included in: |
Transfers | Balance as of September 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
($ in millions) | Net income | OCI | Into Level 3 | Out of Level 3 | Purchases | Sales | Issues | Settlements | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed income securities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Municipal | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
Corporate - public |
|
|
(
|
|
|
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate - privately placed |
|
|
(
|
|
|
|
(
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
ABS |
|
|
|
|
(
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total fixed income securities |
|
|
(
|
|
(
|
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity securities |
|
|
|
|
|
|
(
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Short-term investments |
|
|
|
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Other investments |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Other assets |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Total recurring Level 3 assets | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
Total Level 3 gains (losses) included in net income | ||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Net investment income | $ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||
Net gains (losses) on investments and derivatives |
|
(
|
|
|
Valuation changes included in net income and OCI for Level 3 assets and liabilities held as of September 30, | ||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||
Fixed income securities: | ||||||||||||||||||||||||||
Corporate - privately placed | $ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||
Total fixed income securities |
|
|
(
|
|
||||||||||||||||||||||
Equity securities |
|
(
|
|
|
||||||||||||||||||||||
Other investments |
|
|
(
|
|
||||||||||||||||||||||
Other assets |
|
(
|
|
|
||||||||||||||||||||||
Total recurring Level 3 assets | $ |
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||
|
$ |
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||
Components of net income | ||||||||||||||||||||||||||
Net investment income | $ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||
Net gains (losses) on investments and derivatives |
|
(
|
|
|
||||||||||||||||||||||
Total included in net income | $ |
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||
Assets | ||||||||||||||||||||||||||
Municipal | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Corporate - public |
(
|
(
|
|
(
|
||||||||||||||||||||||
Corporate - privately placed |
(
|
(
|
|
(
|
||||||||||||||||||||||
Changes in unrealized net capital gains and losses reported in OCI | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
Financial instruments not carried at fair value
|
||||||||||||||||||||||||||||||||
($ in millions) | September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||||||||||
Financial assets | Fair value level | Amortized cost, net |
Fair
value
|
Amortized cost, net |
Fair
value
|
|||||||||||||||||||||||||||
Mortgage loans | Level 3 | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Bank loans | Level 3 |
|
|
|
|
|||||||||||||||||||||||||||
Financial liabilities | Fair value level |
Carrying value
(1)
|
Fair
value |
Carrying value
(1)
|
Fair
value
|
|||||||||||||||||||||||||||
Contractholder funds on investment contracts | Level 3 | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Debt | Level 2 |
|
|
|
|
|||||||||||||||||||||||||||
Liability for collateral | Level 2 |
|
|
|
|
|||||||||||||||||||||||||||
Note 6 | Derivative Financial Instruments |
Summary of the volume and fair value positions of derivative instruments as of September 30, 2023 | |||||||||||||||||||||||||||||||||||
($ in millions, except number of contracts) |
Volume
(1)
|
||||||||||||||||||||||||||||||||||
Balance sheet location | Notional amount | Number of contracts | Fair value, net | Gross asset | Gross liability | ||||||||||||||||||||||||||||||
Asset derivatives | |||||||||||||||||||||||||||||||||||
Derivatives not designated as accounting hedging instruments |
|
||||||||||||||||||||||||||||||||||
Interest rate contracts |
|
||||||||||||||||||||||||||||||||||
Futures | Other assets | n/a |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||
Equity and index contracts |
|
||||||||||||||||||||||||||||||||||
Futures | Other assets | n/a |
|
|
|
|
|||||||||||||||||||||||||||||
Foreign currency contracts |
|
||||||||||||||||||||||||||||||||||
Foreign currency forwards | Other investments | $ |
|
n/a |
|
|
(
|
||||||||||||||||||||||||||||
Contingent consideration | Other assets |
|
n/a |
|
|
|
|||||||||||||||||||||||||||||
Credit default contracts |
|
||||||||||||||||||||||||||||||||||
Credit default swaps – buying protection | Other investments |
|
n/a |
|
|
|
|||||||||||||||||||||||||||||
Total asset derivatives | $ |
|
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
Liability derivatives | |||||||||||||||||||||||||||||||||||
Derivatives not designated as accounting hedging instruments | |||||||||||||||||||||||||||||||||||
Interest rate contracts | |||||||||||||||||||||||||||||||||||
Futures | Other liabilities & accrued expenses | n/a |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
Equity and index contracts | |||||||||||||||||||||||||||||||||||
Futures | Other liabilities & accrued expenses | n/a |
|
(
|
|
(
|
|||||||||||||||||||||||||||||
Foreign currency contracts | |||||||||||||||||||||||||||||||||||
Foreign currency forwards | Other liabilities & accrued expenses | $ |
|
n/a |
|
|
(
|
||||||||||||||||||||||||||||
Credit default contracts | |||||||||||||||||||||||||||||||||||
Credit default swaps – buying protection | Other liabilities & accrued expenses |
|
n/a |
(
|
|
(
|
|||||||||||||||||||||||||||||
Total liability derivatives |
|
|
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||||
Total derivatives | $ |
|
|
$ |
|
Summary of the volume and fair value positions of derivative instruments as of December 31, 2022 | |||||||||||||||||||||||||||||||||||
($ in millions, except number of contracts) |
Volume
(1)
|
||||||||||||||||||||||||||||||||||
Balance sheet location | Notional amount | Number of contracts | Fair value, net | Gross asset | Gross liability | ||||||||||||||||||||||||||||||
Asset derivatives | |||||||||||||||||||||||||||||||||||
Derivatives not designated as accounting hedging instruments |
|
||||||||||||||||||||||||||||||||||
Interest rate contracts |
|
||||||||||||||||||||||||||||||||||
Futures | Other assets | n/a |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||
Equity and index contracts |
|
||||||||||||||||||||||||||||||||||
Futures | Other assets | n/a |
|
|
|
|
|||||||||||||||||||||||||||||
Foreign currency contracts |
|
||||||||||||||||||||||||||||||||||
Foreign currency forwards | Other investments | $ |
|
n/a |
|
|
(
|
||||||||||||||||||||||||||||
Contingent consideration | Other assets |
|
n/a |
|
|
|
|||||||||||||||||||||||||||||
Credit default contracts |
|
||||||||||||||||||||||||||||||||||
Credit default swaps – buying protection | Other investments |
|
n/a |
|
|
(
|
|||||||||||||||||||||||||||||
Total asset derivatives | $ |
|
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
Liability derivatives | |||||||||||||||||||||||||||||||||||
Derivatives not designated as accounting hedging instruments | |||||||||||||||||||||||||||||||||||
Interest rate contracts | |||||||||||||||||||||||||||||||||||
Futures | Other liabilities & accrued expenses | n/a |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||
Equity and index contracts | |||||||||||||||||||||||||||||||||||
Futures | Other liabilities & accrued expenses | n/a |
|
(
|
|
(
|
|||||||||||||||||||||||||||||
Foreign currency contracts | |||||||||||||||||||||||||||||||||||
Foreign currency forwards | Other liabilities & accrued expenses | $ |
|
n/a |
|
|
(
|
||||||||||||||||||||||||||||
Credit default contracts | |||||||||||||||||||||||||||||||||||
Credit default swaps – buying protection | Other liabilities & accrued expenses |
|
n/a |
(
|
|
(
|
|||||||||||||||||||||||||||||
Total liability derivatives |
|
|
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||||
Total derivatives | $ |
|
|
$ |
|
Gross and net amounts for OTC derivatives
(1)
|
||||||||||||||||||||||||||||||||||||||
($ in millions) | Offsets | |||||||||||||||||||||||||||||||||||||
Gross amount | Counter-party netting | Cash collateral (received) pledged | Net amount on balance sheet | Securities collateral (received) pledged | Net amount | |||||||||||||||||||||||||||||||||
September 30, 2023 | ||||||||||||||||||||||||||||||||||||||
Asset derivatives | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||
Liability derivatives |
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
December 31, 2022 | ||||||||||||||||||||||||||||||||||||||
Asset derivatives | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||
Liability derivatives |
(
|
|
(
|
(
|
|
(
|
Gains (losses) from valuation and settlements reported on derivatives not designated as accounting hedges
|
||||||||||||||||||||
($ in millions) | Net gains (losses) on investments and derivatives | Operating costs and expenses | Total gain (loss) recognized in net income on derivatives | |||||||||||||||||
Three months ended September 30, 2023 | ||||||||||||||||||||
Interest rate contracts | $ |
|
$ |
|
$ |
|
||||||||||||||
Equity and index contracts |
|
(
|
|
|||||||||||||||||
Contingent consideration |
|
|
|
|||||||||||||||||
Foreign currency contracts |
|
|
|
|||||||||||||||||
Credit default contracts |
(
|
|
(
|
|||||||||||||||||
Total | $ |
|
$ |
(
|
$ |
|
||||||||||||||
Nine months ended September 30, 2023 | ||||||||||||||||||||
Interest rate contracts | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
Equity and index contracts |
(
|
|
|
|||||||||||||||||
Contingent consideration |
|
|
|
|||||||||||||||||
Foreign currency contracts |
|
|
|
|||||||||||||||||
Credit default contracts |
(
|
|
(
|
|||||||||||||||||
Total | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
Three months ended September 30, 2022 | ||||||||||||||||||||
Interest rate contracts | $ |
|
$ |
|
$ |
|
||||||||||||||
Equity and index contracts |
|
(
|
|
|||||||||||||||||
Contingent consideration |
|
(
|
(
|
|||||||||||||||||
Foreign currency contracts |
|
(
|
|
|||||||||||||||||
Credit default contracts |
(
|
|
(
|
|||||||||||||||||
Other contracts |
|
(
|
(
|
|||||||||||||||||
Total | $ |
|
$ |
(
|
$ |
|
||||||||||||||
Nine months ended September 30, 2022 | ||||||||||||||||||||
Interest rate contracts | $ |
|
$ |
|
$ |
|
||||||||||||||
Equity and index contracts |
|
(
|
|
|||||||||||||||||
Contingent consideration |
|
|
|
|||||||||||||||||
Foreign currency contracts |
|
(
|
|
|||||||||||||||||
Credit default contracts |
|
|
|
|||||||||||||||||
Other contracts |
|
(
|
(
|
|||||||||||||||||
Total | $ |
|
$ |
(
|
$ |
|
OTC cash and securities collateral pledged | ||||||||
($ in millions) | September 30, 2023 | |||||||
Pledged by the Company | $ |
|
||||||
Pledged to the Company
(1)
|
|
OTC derivatives counterparty credit exposure by counterparty credit rating
|
||||||||||||||||||||||||||||||||||||||||||||||||||
($ in millions) | September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||
Rating
(1)
|
Number of
counter- parties |
Notional
amount
(2)
|
Credit
exposure
(2)
|
Exposure, net of collateral
(2)
|
Number of
counter- parties |
Notional
amount
(2)
|
Credit
exposure
(2)
|
Exposure, net of collateral
(2)
|
||||||||||||||||||||||||||||||||||||||||||
A+ |
|
$ |
|
$ |
|
$ |
|
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||
A |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Total |
|
$ |
|
$ |
|
$ |
|
|
$ |
|
$ |
|
$ |
|
Exchange traded and cleared margin deposits | ||||||||
($ in millions) | September 30, 2023 | |||||||
Pledged by the Company | $ |
|
||||||
Received by the Company
|
|
($ in millions) | September 30, 2023 | December 31, 2022 | ||||||||||||
Gross liability fair value of contracts containing credit-risk-contingent features | $ |
|
$ |
|
||||||||||
Gross asset fair value of contracts containing credit-risk-contingent features and subject to MNAs |
(
|
(
|
||||||||||||
Collateral posted under MNAs for contracts containing credit-risk-contingent features |
|
(
|
||||||||||||
Maximum amount of additional exposure for contracts with credit-risk-contingent features if all features were triggered concurrently | $ |
|
$ |
|
Note 7 | Variable Interest Entities |
Assets and liabilities of Reciprocal Exchanges
|
||||||||||||||
($ in millions) | September 30, 2023 | December 31, 2022 | ||||||||||||
Assets | ||||||||||||||
Fixed income securities | $ |
|
$ |
|
||||||||||
Short-term investments |
|
|
||||||||||||
Deferred policy acquisition costs |
|
|
||||||||||||
Premium installment and other receivables, net |
|
|
||||||||||||
Reinsurance recoverables, net |
|
|
||||||||||||
Other assets |
|
|
||||||||||||
Total assets |
|
|
||||||||||||
Liabilities | ||||||||||||||
Reserve for property and casualty insurance claims and claims expense |
|
|
||||||||||||
Unearned premiums |
|
|
||||||||||||
Other liabilities and expenses |
|
|
||||||||||||
Total liabilities | $ |
|
$ |
|
Note 8 | Reserve for Property and Casualty Insurance Claims and Claims Expense |
Rollforward of the reserve for property and casualty insurance claims and claims expense
|
||||||||||||||
Nine months ended September 30, | ||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
Balance as of January 1 | $ |
|
$ |
|
||||||||||
Less recoverables
(1)
|
(
|
(
|
||||||||||||
Net balance as of January 1 |
|
|
||||||||||||
Incurred claims and claims expense related to: | ||||||||||||||
Current year |
|
|
||||||||||||
Prior years |
|
|
||||||||||||
Total incurred |
|
|
||||||||||||
Claims and claims expense paid related to: | ||||||||||||||
Current year |
(
|
(
|
||||||||||||
Prior years |
(
|
(
|
||||||||||||
Total paid |
(
|
(
|
||||||||||||
Net balance as of September 30 |
|
|
||||||||||||
Plus recoverables |
|
|
||||||||||||
Balance as of September 30 | $ |
|
$ |
|
Prior year reserve reestimates included in claims and claims expense
(1)
|
||||||||||||||||||||||||||||||||||||||
Non-catastrophe losses | Catastrophe losses | Total | ||||||||||||||||||||||||||||||||||||
($ in millions)
|
2023 | 2022 | 2023 |
|
2022 | 2023 | 2022 | |||||||||||||||||||||||||||||||
Three months ended September 30, | ||||||||||||||||||||||||||||||||||||||
Auto | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||
Homeowners |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Other personal lines |
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||
Commercial lines |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Other business lines |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Run-off Property-Liability
(2)
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Protection Services |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Total prior year reserve reestimates | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||
Nine months ended September 30, |
|
|||||||||||||||||||||||||||||||||||||
Auto | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||
Homeowners |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Other personal lines |
|
(
|
(
|
|
(
|
(
|
||||||||||||||||||||||||||||||||
Commercial lines |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Other business lines |
|
(
|
|
|
|
(
|
||||||||||||||||||||||||||||||||
Run-off Property-Liability
(2)
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Protection Services |
(
|
(
|
|
|
(
|
(
|
||||||||||||||||||||||||||||||||
Total prior year reserve reestimates
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
Note 9 | Reserve for Future Policy Benefits and Contractholder Funds |
Rollforward of reserve for future policy benefits
(1)
|
||||||||||||||||||||||||||||||||||||||
Nine months ended September 30, | ||||||||||||||||||||||||||||||||||||||
Accident and
health |
Traditional
life |
Total | ||||||||||||||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||||||||
Present value of expected net premiums | ||||||||||||||||||||||||||||||||||||||
Beginning balance | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||
Beginning balance at original discount rate |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Effect of changes in cash flow assumptions |
(
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Effect of actual variances from expected experience |
(
|
(
|
|
|
|
(
|
||||||||||||||||||||||||||||||||
Adjusted beginning balance |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Issuances |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Interest accrual |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Net premiums collected |
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||
Ending balance at original discount rate |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Effect of changes in discount rate assumptions |
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||
Ending balance |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Present value of expected future policy benefits | ||||||||||||||||||||||||||||||||||||||
Beginning balance |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Beginning balance at original discount rate |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Effect of changes in cash flow assumptions |
|
(
|
|
|
|
(
|
||||||||||||||||||||||||||||||||
Effect of actual variances from expected experience |
(
|
(
|
|
|
(
|
(
|
||||||||||||||||||||||||||||||||
Adjusted beginning balance |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Issuances |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Interest accrual |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Benefit payments |
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||
Ending balance at original discount rate |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Effect of changes in discount rate assumptions |
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||
Ending balance | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||
Net reserve for future policy benefits
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||
Less: reinsurance recoverables |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Net reserve for future policy benefits, after reinsurance recoverables
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
Revenue and interest recognized in the condensed consolidated statements of operations
|
||||||||||||||||||||||||||
($ in millions) | Nine months ended September 30, | |||||||||||||||||||||||||
2023 | 2022 | |||||||||||||||||||||||||
Revenues
(1)
|
||||||||||||||||||||||||||
Accident and health | $ |
|
$ |
|
||||||||||||||||||||||
Traditional life |
|
|
||||||||||||||||||||||||
Total | $ |
|
$ |
|
||||||||||||||||||||||
Interest expense
(2)
|
||||||||||||||||||||||||||
Accident and health | $ |
|
$ |
|
||||||||||||||||||||||
Traditional life |
|
|
||||||||||||||||||||||||
Total | $ |
|
$ |
|
As of September 30, | ||||||||||||||||||||||||||||||||||||||
2023 | 2022 | |||||||||||||||||||||||||||||||||||||
($ in millions) | Undiscounted | Discounted | Undiscounted | Discounted | ||||||||||||||||||||||||||||||||||
Accident and health | ||||||||||||||||||||||||||||||||||||||
Expected future gross premiums | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
Expected future benefits and expenses |
|
|
|
|
||||||||||||||||||||||||||||||||||
Traditional life | ||||||||||||||||||||||||||||||||||||||
Expected future gross premiums |
|
|
|
|
||||||||||||||||||||||||||||||||||
Expected future benefits and expenses |
|
|
|
|
Key assumptions used in calculating the reserve for future policy benefits
|
||||||||||||||||||||||||||
As of September 30, | ||||||||||||||||||||||||||
Accident and health | Traditional life | |||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Weighted-average duration (in years) |
|
|
|
|
||||||||||||||||||||||
Weighted-average interest rates | ||||||||||||||||||||||||||
Interest accretion rate (discount rate at contract issuance) |
|
% |
|
% |
|
% |
|
% | ||||||||||||||||||
Current discount rate (upper-medium grade fixed income yield) |
|
|
|
|
As of September 30, | ||||||||||||||||||||||||||
Accident and health | Traditional life | |||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Actual to expected experience
|
||||||||||||||||||||||||||
Mortality
|
n/a | n/a |
|
% |
|
% | ||||||||||||||||||||
Morbidity |
|
% |
|
% | n/a | n/a | ||||||||||||||||||||
Lapses |
|
% |
|
% |
|
% |
|
% | ||||||||||||||||||
Contractholder funds activity
|
||||||||||||||
Nine months ended September 30,
|
||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
Beginning balance | $ |
|
$ |
|
||||||||||
Deposits |
|
|
||||||||||||
Interest credited |
|
|
||||||||||||
Benefits |
(
|
(
|
||||||||||||
Surrenders and partial withdrawals |
(
|
(
|
||||||||||||
Contract charges |
(
|
(
|
||||||||||||
Other adjustments |
(
|
(
|
||||||||||||
Ending balance | $ |
|
$ |
|
||||||||||
Components of contractholder funds | ||||||||||||||
Interest-sensitive life insurance | $ |
|
$ |
|
||||||||||
Fixed annuities |
|
|
||||||||||||
Total | $ |
|
$ |
|
||||||||||
Weighted-average crediting rate |
|
% |
|
% | ||||||||||
Net amount at risk
(1)
|
$ |
|
$ |
|
||||||||||
Cash surrender value |
|
|
Account values: comparison of current crediting rate to guaranteed minimum crediting rate
(1)
|
||||||||||||||||||||||||||||||||||||||
($ in millions)
Range of guaranteed minimum crediting rates
|
At guaranteed minimum |
|
Total | |||||||||||||||||||||||||||||||||||
September 30, 2023 | ||||||||||||||||||||||||||||||||||||||
Less than
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||||||
Non-account balances
(2)
|
|
|
|
|||||||||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
September 30, 2022 | ||||||||||||||||||||||||||||||||||||||
Less than
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||||||
Non-account balances
(2)
|
|
|
|
|||||||||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
Note 10 | Reinsurance and Indemnification |
Effects of reinsurance ceded and indemnification programs on property and casualty premiums earned and accident and health insurance premiums and contract charges
|
||||||||||||||||||||||||||
($ in millions) | Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Property and casualty insurance premiums earned | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Accident and health insurance premiums and contract charges |
(
|
(
|
(
|
(
|
Effects of reinsurance ceded and indemnification programs on property and casualty insurance claims and claims expense and accident, health and other policy benefits
|
||||||||||||||||||||||||||
($ in millions) | Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Property and casualty insurance claims and claims expense
(1)
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Accident, health and other policy benefits
|
(
|
|
(
|
|
Reinsurance and indemnification recoverables, net | ||||||||||||||
($ in millions) | September 30, 2023 | December 31, 2022 | ||||||||||||
Property and casualty | ||||||||||||||
Paid and due from reinsurers and indemnitors | $ |
|
$ |
|
||||||||||
Unpaid losses estimated (including IBNR) |
|
|
||||||||||||
Total property and casualty | $ |
|
$ |
|
||||||||||
Accident and health insurance |
|
|
||||||||||||
Total | $ |
|
$ |
|
Rollforward of credit loss allowance for reinsurance recoverables | ||||||||||||||||||||||||||
($ in millions) | Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Property and casualty
(1) (2)
|
||||||||||||||||||||||||||
Beginning balance | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
(Increase) decrease in the provision for credit losses |
|
(
|
|
(
|
||||||||||||||||||||||
Write-offs |
|
|
|
|
||||||||||||||||||||||
Ending balance | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Accident and health insurance | ||||||||||||||||||||||||||
Beginning balance | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Increase in the provision for credit losses |
|
|
|
|
||||||||||||||||||||||
Write-offs |
|
|
|
|
||||||||||||||||||||||
Ending balance | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
Note 11 | Deferred Policy Acquisition Costs |
Deferred policy acquisition costs activity
|
||||||||||||||||||||||||||||||||
($ in millions) | Accident and health |
Traditional
life |
Interest-sensitive life | Total | ||||||||||||||||||||||||||||
Nine months ended September 30, 2023 | ||||||||||||||||||||||||||||||||
Accident and health insurance | ||||||||||||||||||||||||||||||||
Long-duration contracts | ||||||||||||||||||||||||||||||||
Beginning balance | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||
Acquisition costs deferred |
|
|
|
|
||||||||||||||||||||||||||||
Amortization charged to income |
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||
Experience adjustment |
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
|
|||||||||||||||||||||||||
Short-duration contracts |
|
|||||||||||||||||||||||||||||||
Property and casualty |
|
|||||||||||||||||||||||||||||||
Ending balance | $ |
|
||||||||||||||||||||||||||||||
Nine months ended September 30, 2022 | ||||||||||||||||||||||||||||||||
Accident and health insurance | ||||||||||||||||||||||||||||||||
Long-duration contracts | ||||||||||||||||||||||||||||||||
Beginning balance | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||
Acquisition costs deferred |
|
|
|
|
||||||||||||||||||||||||||||
Amortization charged to income |
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||
Experience adjustment |
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
|
|||||||||||||||||||||||||
Short-duration contracts |
|
|||||||||||||||||||||||||||||||
Property and casualty |
|
|||||||||||||||||||||||||||||||
Ending balance | $ |
|
Note 12 | Capital Structure |
Interest rates for LIBOR-linked debt | ||||||||||||||||||||
($ in millions) |
|
|
||||||||||||||||||
Debt outstanding | $ |
|
$ |
|
||||||||||||||||
Dividend accrual date
(1)
|
July 15, 2023 | August 15, 2023 | ||||||||||||||||||
Rate following commencement date |
3-month SOFR +
|
3-month SOFR
+
|
Note 13 | Company Restructuring |
Organizational transformation
|
||||||||
($ in millions) | ||||||||
Expected program charges | $ |
|
||||||
2023 expenses
|
(
|
|||||||
Remaining program charges | $ |
|
Restructuring activity during the period | ||||||||||||||||||||
($ in millions) |
Employee
costs
|
Exit
costs
|
Total
liability
|
|||||||||||||||||
Restructuring liability as of December 31, 2022 | $ |
|
$ |
|
$ |
|
||||||||||||||
Expense incurred
|
|
|
|
|||||||||||||||||
Adjustments to liability |
(
|
(
|
(
|
|||||||||||||||||
Payments and non-cash charges |
(
|
(
|
(
|
|||||||||||||||||
Restructuring liability as of September 30, 2023 | $ |
|
$ |
|
$ |
|
Note 14 | Guarantees and Contingent Liabilities |
Note 15 | Benefit Plans |
Components of net cost (benefit) for pension and other postretirement plans | ||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Pension benefits | ||||||||||||||||||||||||||
Service cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Interest cost |
|
|
|
|
||||||||||||||||||||||
Expected return on plan assets |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Amortization of prior service credit |
|
(
|
|
(
|
||||||||||||||||||||||
Costs and expenses |
|
(
|
|
(
|
||||||||||||||||||||||
Remeasurement of projected benefit obligation |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Remeasurement of plan assets |
|
|
|
|
||||||||||||||||||||||
Remeasurement (gains) losses |
|
|
|
|
||||||||||||||||||||||
Pension net cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Postretirement benefits | ||||||||||||||||||||||||||
Service cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Interest cost |
|
|
|
|
||||||||||||||||||||||
Amortization of prior service credit |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Costs and expenses |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Remeasurement of projected benefit obligation |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Remeasurement of plan assets |
|
|
|
|
||||||||||||||||||||||
Remeasurement (gains) losses |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Postretirement net benefit | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Pension and postretirement benefits | ||||||||||||||||||||||||||
Costs and expenses | $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
Remeasurement (gains) losses |
|
|
|
|
||||||||||||||||||||||
Total net cost (benefit) | $ |
|
$ |
|
$ |
|
$ |
(
|
Pension and postretirement benefits remeasurement gains and losses | ||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Remeasurement of projected benefit obligation (gains) losses: | ||||||||||||||||||||||||||
Discount rate | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Other assumptions |
|
|
|
(
|
||||||||||||||||||||||
Remeasurement of plan assets (gains) losses |
|
|
|
|
||||||||||||||||||||||
Remeasurement (gains) losses | $ |
|
$ |
|
$ |
|
$ |
|
Note 16 | Supplemental Cash Flow Information |
($ in millions) | Nine months ended September 30, | |||||||||||||
2023 | 2022 | |||||||||||||
Net change in proceeds managed | ||||||||||||||
Net change in fixed income securities | $ |
|
$ |
(
|
||||||||||
Net change in short-term investments |
|
(
|
||||||||||||
Operating cash flow provided (used) |
|
(
|
||||||||||||
Net change in cash |
|
|
||||||||||||
Net change in proceeds managed | $ |
|
$ |
(
|
||||||||||
Cash flows from operating activities
|
||||||||||||||
Net change in liabilities | ||||||||||||||
Liabilities for collateral, beginning of period | $ |
(
|
$ |
(
|
||||||||||
Liabilities for collateral, end of period |
(
|
(
|
||||||||||||
Operating cash flow (used) provided | $ |
(
|
$ |
|
Note 17 | Other Comprehensive Income (Loss) |
Components of other comprehensive income (loss) on a pre-tax and after-tax basis
|
||||||||||||||||||||||||||||||||||||||
($ in millions) | Three months ended September 30, | |||||||||||||||||||||||||||||||||||||
2023 | 2022 | |||||||||||||||||||||||||||||||||||||
Pre-tax | Tax | After-tax | Pre-tax | Tax | After-tax | |||||||||||||||||||||||||||||||||
Unrealized net holding gains and losses arising during the period, net of related offsets | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
Less: reclassification adjustment of realized capital gains and losses |
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
Unrealized net capital gains and losses |
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
Unrealized foreign currency translation adjustments |
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
Unamortized pension and other postretirement prior service credit
(1)
|
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
Discount rate for reserve for future policy benefits
|
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
Other comprehensive (loss) income | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
Nine months ended September 30, | ||||||||||||||||||||||||||||||||||||||
2023 | 2022 | |||||||||||||||||||||||||||||||||||||
Pre-tax | Tax | After-tax | Pre-tax | Tax | After-tax | |||||||||||||||||||||||||||||||||
Unrealized net holding gains and losses arising during the period, net of related offsets | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
Less: reclassification adjustment of realized capital gains and losses |
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
Unrealized net capital gains and losses |
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
Unrealized foreign currency translation adjustments |
|
(
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
Unamortized pension and other postretirement prior service credit
(1)
|
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
Discount rate for reserve for future policy benefits |
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
Other comprehensive (loss) income | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
• | Net gains and losses on investments and derivatives | ||||
• | Pension and other postretirement remeasurement gains and losses | ||||
• | Amortization or impairment of purchased intangibles | ||||
• | Gain or loss on disposition | ||||
• | Adjustments for other significant non-recurring, infrequent or unusual items, when (a) the nature of the charge or gain is such that it is reasonably unlikely to recur within two years, or (b) there has been no similar charge or gain within the prior two years | ||||
• | Income tax expense or benefit on reconciling items |
Consolidated net income (loss) applicable to common shareholders | ||||||||||||||
($ in millions) | ||||||||||||||
Q1 | Q2 | Q3 |
Consolidated net loss applicable to common shareholders
was $41 million in the third quarter of 2023 compared to a loss of $685 million in the third quarter of 2022, primarily due to higher Property-Liability premiums earned and lower unfavorable prior year reserve reestimates. Net loss was $1.78 billion in the first nine months of 2023 compared to a loss of $1.09 billion in the first nine months of 2022 primarily due to higher catastrophe losses and higher incurred losses driven by severity, partially offset by increased Property-Liability premiums earned, lower unfavorable prior year reserve reestimates and gains on equity valuations in 2023 compared to losses in 2022.
For the nine months ended September 30, 2023, return on Allstate common shareholders’ equity was (14.7)%.
|
||
Total revenue | ||||||||||||||
($ in millions) |
Total revenues
increased 9.8% to $14.50 billion and increased 11.9% to $42.26 billion in the third quarter and first nine months of 2023, respectively, compared to the same periods of 2022 due to an increase of 10.1% and 10.2% in property and casualty insurance premiums earned in the third quarter and first nine months of 2023, respectively, compared to the third quarter and first nine months of 2022 and net gains on equity valuations in the first nine months of 2023 compared to losses in 2022.
|
Net investment income | ||||||||||||||
($ in millions) |
Net investment income
decreased $1 million to $689 million in the third quarter of 2023, primarily due to lower performance-based investment results, partially offset by higher market-based income reflecting higher fixed income portfolio yields and investment balances. Net investment income increased $28 million to $1.87 billion in the first nine months of 2023 compared to the same periods of 2022, primarily due to higher market-based income reflecting higher fixed income portfolio yields and investment balances, partially offset by lower performance-based investment results.
|
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||
Property and casualty insurance premiums | $ | 12,839 | $ | 11,661 | $ | 37,482 | $ | 34,004 | ||||||||||||||||||
Accident and health insurance premiums and contract charges | 463 | 463 | 1,379 | 1,396 | ||||||||||||||||||||||
Other revenue | 592 | 561 | 1,750 | 1,684 | ||||||||||||||||||||||
Net investment income | 689 | 690 | 1,874 | 1,846 | ||||||||||||||||||||||
Net gains (losses) on investments and derivatives | (86) | (167) | (223) | (1,167) | ||||||||||||||||||||||
Total revenues | 14,497 | 13,208 | 42,262 | 37,763 | ||||||||||||||||||||||
Costs and expenses | ||||||||||||||||||||||||||
Property and casualty insurance claims and claims expense | (10,237) | (10,073) | (32,290) | (27,262) | ||||||||||||||||||||||
Accident, health and other policy benefits | (262) | (252) | (785) | (785) | ||||||||||||||||||||||
Amortization of deferred policy acquisition costs | (1,841) | (1,683) | (5,374) | (4,909) | ||||||||||||||||||||||
Operating, restructuring and interest expenses | (1,946) | (1,941) | (5,686) | (5,872) | ||||||||||||||||||||||
Pension and other postretirement remeasurement gains (losses) | (149) | (79) | (56) | (91) | ||||||||||||||||||||||
Amortization of purchased intangibles | (83) | (90) | (246) | (264) | ||||||||||||||||||||||
Total costs and expenses | (14,518) | (14,118) | (44,437) | (39,183) | ||||||||||||||||||||||
Loss from operations before income tax expense | (21) | (910) | (2,175) | (1,420) | ||||||||||||||||||||||
Income tax benefit | 17 | 236 | 475 | 374 | ||||||||||||||||||||||
Net loss | (4) | (674) | (1,700) | (1,046) | ||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interest | 1 | (15) | (23) | (34) | ||||||||||||||||||||||
Net loss attributable to Allstate | (5) | (659) | (1,677) | (1,012) | ||||||||||||||||||||||
Preferred stock dividends | (36) | (26) | (99) | (79) | ||||||||||||||||||||||
Net loss applicable to common shareholders | $ | (41) | $ | (685) | $ | (1,776) | $ | (1,091) |
After-tax cumulative effect of change in accounting principle on transition date | ||||||||||||||||||||
($ in millions) | January 1, 2021 | |||||||||||||||||||
Decrease in retained income | $ | 21 | ||||||||||||||||||
Decrease in accumulated other comprehensive income (“AOCI”) | 277 | |||||||||||||||||||
Total decrease in equity | $ | 298 |
Underwriting results
|
||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||
($ in millions, except ratios) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Premiums written | $ | 13,304 | $ | 12,037 | $ | 37,707 | $ | 34,307 | ||||||||||||||||||
Premiums earned | $ | 12,270 | $ | 11,157 | $ | 35,826 | $ | 32,529 | ||||||||||||||||||
Other revenue | 393 | 364 | 1,135 | 1,066 | ||||||||||||||||||||||
Claims and claims expense | (10,077) | (9,934) | (31,832) | (26,867) | ||||||||||||||||||||||
Amortization of DAC | (1,533) | (1,414) | (4,481) | (4,117) | ||||||||||||||||||||||
Other costs and expenses | (1,333) | (1,390) | (3,861) | (4,285) | ||||||||||||||||||||||
Restructuring and related charges
(1)
|
(74) | (14) | (121) | (24) | ||||||||||||||||||||||
Amortization of purchased intangibles | (60) | (61) | (175) | (178) | ||||||||||||||||||||||
Underwriting (loss) income | $ | (414) | $ | (1,292) | $ | (3,509) | $ | (1,876) | ||||||||||||||||||
Catastrophe losses | ||||||||||||||||||||||||||
Catastrophe losses, excluding reserve reestimates | $ | 1,164 | $ | 772 | $ | 5,562 | $ | 2,304 | ||||||||||||||||||
Catastrophe reserve reestimates
(2)
|
17 | (9) | 6 | 29 | ||||||||||||||||||||||
Total catastrophe losses | $ | 1,181 | $ | 763 | $ | 5,568 | $ | 2,333 | ||||||||||||||||||
Non-catastrophe reserve reestimates
(2)
|
$ | 166 | $ | 875 | $ | 375 | $ | 1,444 | ||||||||||||||||||
Prior year reserve reestimates
(2)
|
183 | 866 | 381 | 1,473 | ||||||||||||||||||||||
GAAP operating ratios | ||||||||||||||||||||||||||
Loss ratio | 82.2 | 89.0 | 88.9 | 82.6 | ||||||||||||||||||||||
Expense ratio
(3)
|
21.2 | 22.6 | 20.9 | 23.2 | ||||||||||||||||||||||
Combined ratio | 103.4 | 111.6 | 109.8 | 105.8 | ||||||||||||||||||||||
Effect of catastrophe losses on combined ratio | 9.6 | 6.8 | 15.5 | 7.2 | ||||||||||||||||||||||
Effect of prior year reserve reestimates on combined ratio | 1.5 | 7.7 | 1.1 | 4.6 | ||||||||||||||||||||||
Effect of catastrophe losses included in prior year reserve reestimates on combined ratio | 0.1 | (0.1) | — | 0.1 | ||||||||||||||||||||||
Effect of restructuring and related charges on combined ratio
(1)
|
0.6 | 0.1 | 0.3 | 0.1 | ||||||||||||||||||||||
Effect of amortization of purchased intangibles on combined ratio | 0.5 | 0.6 | 0.5 | 0.5 | ||||||||||||||||||||||
Effect of Run-off Property-Liability business on combined ratio | 0.7 | 1.1 | 0.3 | 0.4 |
Underwriting results
|
||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Premiums written | $ | 13,304 | $ | 12,037 | $ | 37,707 | $ | 34,307 | ||||||||||||||||||
Premiums earned | $ | 12,270 | $ | 11,157 | $ | 35,826 | $ | 32,529 | ||||||||||||||||||
Other revenue | 393 | 364 | 1,135 | 1,066 | ||||||||||||||||||||||
Claims and claims expense | (9,995) | (9,814) | (31,747) | (26,743) | ||||||||||||||||||||||
Amortization of DAC | (1,533) | (1,414) | (4,481) | (4,117) | ||||||||||||||||||||||
Other costs and expenses | (1,332) | (1,388) | (3,858) | (4,282) | ||||||||||||||||||||||
Restructuring and related charges | (74) | (14) | (121) | (24) | ||||||||||||||||||||||
Amortization of purchased intangibles | (60) | (61) | (175) | (178) | ||||||||||||||||||||||
Underwriting loss | $ | (331) | $ | (1,170) | $ | (3,421) | $ | (1,749) | ||||||||||||||||||
Catastrophe losses | $ | 1,181 | $ | 763 | $ | 5,568 | $ | 2,333 | ||||||||||||||||||
Change in underwriting results from prior year period - three months ended | ||||||||||||||
($ in millions) |
Change in underwriting results from prior year period - nine months ended
|
||||||||||||||
($ in millions) |
Underwriting income (loss) by brand and by line of business
|
||||||||||||||||||||||||||||||||||||||
Allstate brand | National General | Allstate Protection | ||||||||||||||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||||||||
Three months ended September 30, | ||||||||||||||||||||||||||||||||||||||
Auto
|
$ | (75) | $ | (1,222) | $ | (103) | $ | (93) | $ | (178) | $ | (1,315) | ||||||||||||||||||||||||||
Homeowners
(1)
|
(69) | 268 | (62) | (2) | (131) | 266 | ||||||||||||||||||||||||||||||||
Other personal lines
|
1 | (3) | 5 | (7) | 6 | (10) | ||||||||||||||||||||||||||||||||
Commercial lines
|
(54) | (116) | (6) | (1) | (60) | (117) | ||||||||||||||||||||||||||||||||
Other business lines
(1)
|
29 | 24 | (1) | (21) | 28 | 3 | ||||||||||||||||||||||||||||||||
Answer Financial | — | — | — | — | 4 | 3 | ||||||||||||||||||||||||||||||||
Total | $ | (168) | $ | (1,049) | $ | (167) | $ | (124) | $ | (331) | $ | (1,170) | ||||||||||||||||||||||||||
Nine months ended September 30, | ||||||||||||||||||||||||||||||||||||||
Auto
|
$ | (953) | $ | (1,937) | $ | (249) | $ | (103) | $ | (1,202) | $ | (2,040) | ||||||||||||||||||||||||||
Homeowners
(1)
|
(1,772) | 504 | (200) | (30) | (1,972) | 474 | ||||||||||||||||||||||||||||||||
Other personal lines | (159) | 20 | 6 | (1) | (153) | 19 | ||||||||||||||||||||||||||||||||
Commercial lines | (178) | (280) | (3) | 6 | (181) | (274) | ||||||||||||||||||||||||||||||||
Other business lines
(1)
|
75 | 70 | 3 | (5) | 78 | 65 | ||||||||||||||||||||||||||||||||
Answer Financial | — | — | — | — | 9 | 7 | ||||||||||||||||||||||||||||||||
Total | $ | (2,987) | $ | (1,623) | $ | (443) | $ | (133) | $ | (3,421) | $ | (1,749) |
Premiums written by brand and by line of business
|
||||||||||||||||||||||||||||||||||||||
Allstate brand | National General | Allstate Protection | ||||||||||||||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||||||||
Three months ended September 30, | ||||||||||||||||||||||||||||||||||||||
Auto | $ | 7,206 | $ | 6,704 | $ | 1,564 | $ | 1,156 | $ | 8,770 | $ | 7,860 | ||||||||||||||||||||||||||
Homeowners | 3,118 | 2,803 | 407 | 342 | 3,525 | 3,145 | ||||||||||||||||||||||||||||||||
Other personal lines | 621 | 564 | 55 | 42 | 676 | 606 | ||||||||||||||||||||||||||||||||
Commercial lines | 75 | 233 | 65 | 52 | 140 | 285 | ||||||||||||||||||||||||||||||||
Other business lines | — | — | 193 | 141 | 193 | 141 | ||||||||||||||||||||||||||||||||
Total premiums written | $ | 11,020 | $ | 10,304 | $ | 2,284 | $ | 1,733 | $ | 13,304 | $ | 12,037 | ||||||||||||||||||||||||||
Nine months ended September 30, | ||||||||||||||||||||||||||||||||||||||
Auto | $ | 20,853 | $ | 19,386 | $ | 4,535 | $ | 3,506 | $ | 25,388 | $ | 22,892 | ||||||||||||||||||||||||||
Homeowners | 8,265 | 7,488 | 1,175 | 946 | 9,440 | 8,434 | ||||||||||||||||||||||||||||||||
Other personal lines | 1,734 | 1,609 | 165 | 110 | 1,899 | 1,719 | ||||||||||||||||||||||||||||||||
Commercial lines | 398 | 718 | 169 | 158 | 567 | 876 | ||||||||||||||||||||||||||||||||
Other business lines | — | — | 413 | 386 | 413 | 386 | ||||||||||||||||||||||||||||||||
Total premiums written | $ | 31,250 | $ | 29,201 | $ | 6,457 | $ | 5,106 | $ | 37,707 | $ | 34,307 |
Premiums earned by brand and by line of business
|
||||||||||||||||||||||||||||||||||||||
Allstate brand | National General | Allstate Protection | ||||||||||||||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||||||||
Three months ended September 30, | ||||||||||||||||||||||||||||||||||||||
Auto | $ | 6,910 | $ | 6,416 | $ | 1,435 | $ | 1,129 | $ | 8,345 | $ | 7,545 | ||||||||||||||||||||||||||
Homeowners | 2,613 | 2,350 | 356 | 292 | 2,969 | 2,642 | ||||||||||||||||||||||||||||||||
Other personal lines | 554 | 505 | 54 | 35 | 608 | 540 | ||||||||||||||||||||||||||||||||
Commercial lines | 138 | 246 | 56 | 50 | 194 | 296 | ||||||||||||||||||||||||||||||||
Other business lines | — | — | 154 | 134 | 154 | 134 | ||||||||||||||||||||||||||||||||
Total premiums earned | $ | 10,215 | $ | 9,517 | $ | 2,055 | $ | 1,640 | $ | 12,270 | $ | 11,157 | ||||||||||||||||||||||||||
Nine months ended September 30, | ||||||||||||||||||||||||||||||||||||||
Auto | $ | 20,342 | $ | 18,742 | $ | 4,032 | $ | 3,232 | $ | 24,374 | $ | 21,974 | ||||||||||||||||||||||||||
Homeowners | 7,638 | 6,841 | 1,024 | 857 | 8,662 | 7,698 | ||||||||||||||||||||||||||||||||
Other personal lines | 1,615 | 1,511 | 142 | 105 | 1,757 | 1,616 | ||||||||||||||||||||||||||||||||
Commercial lines | 474 | 722 | 154 | 152 | 628 | 874 | ||||||||||||||||||||||||||||||||
Other business lines | — | — | 405 | 367 | 405 | 367 | ||||||||||||||||||||||||||||||||
Total premiums earned | $ | 30,069 | $ | 27,816 | $ | 5,757 | $ | 4,713 | $ | 35,826 | $ | 32,529 |
Reconciliation of premiums written to premiums earned | ||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Total premiums written | $ | 13,304 | $ | 12,037 | $ | 37,707 | $ | 34,307 | ||||||||||||||||||
(Increase) decrease in unearned premiums
|
(1,082) | (852) | (1,962) | (1,709) | ||||||||||||||||||||||
Other | 48 | (28) | 81 | (69) | ||||||||||||||||||||||
Total premiums earned | $ | 12,270 | $ | 11,157 | $ | 35,826 | $ | 32,529 |
Policies in force by brand and by line of business
|
||||||||||||||||||||||||||||||||||||||
Allstate brand | National General | Allstate Protection | ||||||||||||||||||||||||||||||||||||
PIF (thousands) | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||||||||
Auto | 20,546 | 21,853 | 4,830 | 4,278 | 25,376 | 26,131 | ||||||||||||||||||||||||||||||||
Homeowners | 6,627 | 6,599 | 670 | 638 | 7,297 | 7,237 | ||||||||||||||||||||||||||||||||
Other personal lines | 4,555 | 4,637 | 329 | 293 | 4,884 | 4,930 | ||||||||||||||||||||||||||||||||
Commercial lines | 174 | 204 | 122 | 106 | 296 | 310 | ||||||||||||||||||||||||||||||||
Total | 31,902 | 33,293 | 5,951 | 5,315 | 37,853 | 38,608 |
Auto premium measures and statistics
|
||||||||||||||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||||||||||||||
2023 | 2022 | Change | 2023 | 2022 | Change | |||||||||||||||||||||||||||||||||
New issued applications (thousands) | ||||||||||||||||||||||||||||||||||||||
Allstate Protection by brand | ||||||||||||||||||||||||||||||||||||||
Allstate brand | 751 | 933 | (19.5) | % | 2,226 | 2,856 | (22.1) | % | ||||||||||||||||||||||||||||||
National General | 754 | 648 | 16.4 | % | 2,291 | 2,038 | 12.4 | % | ||||||||||||||||||||||||||||||
Total new issued applications | 1,505 | 1,581 | (4.8) | % | 4,517 | 4,894 | (7.7) | % | ||||||||||||||||||||||||||||||
Allstate Protection by channel | ||||||||||||||||||||||||||||||||||||||
Exclusive agency channel | 582 | 624 | (6.7) | % | 1,745 | 1,842 | (5.3) | % | ||||||||||||||||||||||||||||||
Direct channel | 398 | 535 | (25.6) | % | 1,276 | 1,737 | (26.5) | % | ||||||||||||||||||||||||||||||
Independent agency channel | 525 | 422 | 24.4 | % | 1,496 | 1,315 | 13.8 | % | ||||||||||||||||||||||||||||||
Total new issued applications | 1,505 | 1,581 | (4.8) | % | 4,517 | 4,894 | (7.7) | % | ||||||||||||||||||||||||||||||
Allstate brand average premium | $ | 772 | $ | 667 | 15.7 | % | $ | 745 | $ | 646 | 15.3 | % | ||||||||||||||||||||||||||
Allstate brand renewal ratio (%) | 84.9 | 87.0 | (2.1) | 85.4 | 87.3 | (1.9) | ||||||||||||||||||||||||||||||||
Homeowners premium measures and statistics
|
||||||||||||||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||||||||||||||
2023 | 2022 | Change | 2023 | 2022 | Change | |||||||||||||||||||||||||||||||||
New issued applications (thousands) | ||||||||||||||||||||||||||||||||||||||
Allstate Protection by brand | ||||||||||||||||||||||||||||||||||||||
Allstate brand | 248 | 267 | (7.1) | % | 712 | 765 | (6.9) | % | ||||||||||||||||||||||||||||||
National General | 54 | 41 | 31.7 | % | 135 | 108 | 25.0 | % | ||||||||||||||||||||||||||||||
Total new issued applications | 302 | 308 | (1.9) | % | 847 | 873 | (3.0) | % | ||||||||||||||||||||||||||||||
Allstate Protection by channel | ||||||||||||||||||||||||||||||||||||||
Exclusive agency channel | 211 | 219 | (3.7) | % | 609 | 642 | (5.1) | % | ||||||||||||||||||||||||||||||
Direct channel | 22 | 24 | (8.3) | % | 60 | 74 | (18.9) | % | ||||||||||||||||||||||||||||||
Independent agency channel | 69 | 65 | 6.2 | % | 178 | 157 | 13.4 | % | ||||||||||||||||||||||||||||||
Total new issued applications | 302 | 308 | (1.9) | % | 847 | 873 | (3.0) | % | ||||||||||||||||||||||||||||||
Allstate brand average premium | $ | 1,851 | $ | 1,635 | 13.2 | % | $ | 1,792 | $ | 1,596 | 12.3 | % | ||||||||||||||||||||||||||
Allstate brand renewal ratio (%) | 86.8 | 87.4 | (0.6) | 86.5 | 86.9 | (0.4) | ||||||||||||||||||||||||||||||||
Combined ratios by line of business
|
||||||||||||||||||||||||||||||||||||||
Loss ratio |
Expense ratio
(1)
|
Combined ratio | ||||||||||||||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||||||||||||
Three months ended September 30, | ||||||||||||||||||||||||||||||||||||||
Auto
|
81.4 | 95.3 | 20.7 | 22.1 | 102.1 | 117.4 | ||||||||||||||||||||||||||||||||
Homeowners | 82.4 | 67.4 | 22.0 | 22.5 | 104.4 | 89.9 | ||||||||||||||||||||||||||||||||
Other personal lines | 78.6 | 76.1 | 20.4 | 25.8 | 99.0 | 101.9 | ||||||||||||||||||||||||||||||||
Commercial lines | 102.0 | 120.6 | 28.9 | 18.9 | 130.9 | 139.5 | ||||||||||||||||||||||||||||||||
Other business lines | 49.3 | 56.7 | 32.5 | 41.1 | 81.8 | 97.8 | ||||||||||||||||||||||||||||||||
Total | 81.5 | 88.0 | 21.2 | 22.5 | 102.7 | 110.5 | ||||||||||||||||||||||||||||||||
Impact of amortization of purchased intangibles | 0.5 | 0.6 | 0.5 | 0.6 | ||||||||||||||||||||||||||||||||||
Impact of restructuring and related charges | 0.6 | 0.1 | 0.6 | 0.1 | ||||||||||||||||||||||||||||||||||
Nine months ended September 30, | ||||||||||||||||||||||||||||||||||||||
Auto | 84.2 | 86.1 | 20.7 | 23.2 | 104.9 | 109.3 | ||||||||||||||||||||||||||||||||
Homeowners | 101.8 | 71.3 | 21.0 | 22.5 | 122.8 | 93.8 | ||||||||||||||||||||||||||||||||
Other personal lines | 88.4 | 74.4 | 20.3 | 24.4 | 108.7 | 98.8 | ||||||||||||||||||||||||||||||||
Commercial lines | 103.2 | 112.0 | 25.6 | 19.4 | 128.8 | 131.4 | ||||||||||||||||||||||||||||||||
Other business lines | 48.1 | 41.7 | 32.6 | 40.6 | 80.7 | 82.3 | ||||||||||||||||||||||||||||||||
Total | 88.6 | 82.2 | 20.9 | 23.2 | 109.5 | 105.4 | ||||||||||||||||||||||||||||||||
Impact of amortization of purchased intangibles | 0.5 | 0.5 | 0.5 | 0.5 | ||||||||||||||||||||||||||||||||||
Impact of restructuring and related charges | 0.3 | 0.1 | 0.3 | 0.1 |
Loss ratios by line of business
|
||||||||||||||||||||||||||||||||||||||||||||||||||
Loss ratio |
Effect of catastrophe losses
(1)
|
Effect of prior year reserve reestimates | Effect of catastrophe losses included in prior year reserve reestimates | |||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||||||||||||||||||||||
Three months ended September 30, | ||||||||||||||||||||||||||||||||||||||||||||||||||
Auto | 81.4 | 95.3 | 2.6 | 4.4 | 0.4 | 8.4 | 0.1 | (0.1) | ||||||||||||||||||||||||||||||||||||||||||
Homeowners | 82.4 | 67.4 | 29.6 | 13.4 | 2.1 | 2.0 | 0.6 | 0.1 | ||||||||||||||||||||||||||||||||||||||||||
Other personal lines | 78.6 | 76.1 | 9.7 | 5.7 | (2.3) | (0.9) | (1.8) | (0.6) | ||||||||||||||||||||||||||||||||||||||||||
Commercial lines | 102.0 | 120.6 | 5.2 | 3.4 | 9.8 | 21.6 | 3.1 | 0.4 | ||||||||||||||||||||||||||||||||||||||||||
Other business lines | 49.3 | 56.7 | 13.0 | 27.6 | 0.7 | 1.5 | — | 0.7 | ||||||||||||||||||||||||||||||||||||||||||
Total | 81.5 | 88.0 | 9.6 | 6.8 | 0.8 | 6.7 | 0.1 | (0.1) | ||||||||||||||||||||||||||||||||||||||||||
Nine months ended September 30, | ||||||||||||||||||||||||||||||||||||||||||||||||||
Auto | 84.2 | 86.1 | 2.7 | 2.2 | 0.4 | 4.6 | (0.1) | (0.3) | ||||||||||||||||||||||||||||||||||||||||||
Homeowners | 101.8 | 71.3 | 52.1 | 21.4 | 1.6 | 2.3 | 0.7 | 1.0 | ||||||||||||||||||||||||||||||||||||||||||
Other personal lines | 88.4 | 74.4 | 19.1 | 8.4 | (0.5) | (0.9) | (1.3) | 0.2 | ||||||||||||||||||||||||||||||||||||||||||
Commercial lines | 103.2 | 112.0 | 4.3 | 2.1 | 8.1 | 20.0 | 1.4 | 0.1 | ||||||||||||||||||||||||||||||||||||||||||
Other business lines | 48.1 | 41.7 | 9.4 | 12.8 | 2.9 | (1.1) | — | 1.3 | ||||||||||||||||||||||||||||||||||||||||||
Total | 88.6 | 82.2 | 15.5 | 7.2 | 0.8 | 4.2 | — | 0.1 |
Auto underwriting results
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
For the periods ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
($ in millions, except ratios) | Q3 | Q2 | Q1 | Q4 | Q3 | Q2 | Q1 | Q4 | Q3 | Q2 | Q1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Underwriting income (loss) | (178) | (678) | (346) | (974) | (1,315) | (578) | (147) | (300) | (159) | 394 | 1,327 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss ratio | 81.4 | 87.9 | 83.4 | 90.6 | 95.3 | 84.9 | 77.6 | 78.9 | 76.9 | 68.7 | 57.2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Effect of prior year non-catastrophe reserve reestimates on combined ratio
|
0.3 | 1.4 | (0.1) | 2.3 | 8.5 | 3.8 | 2.1 | 2.1 | 1.1 | (0.4) | (0.2) |
Allstate brand homeowners frequency and severity statistics (excluding catastrophe losses)
|
||||||||
(% change year-over-year) | ||||||||
Three months ended September 30, 2023 | ||||||||
Gross claim frequency | (4.3) | % | ||||||
Paid claim severity | 16.0 | |||||||
Nine months ended September 30, 2023 | ||||||||
Gross claim frequency | (3.0) | % | ||||||
Paid claim severity | 12.9 |
Catastrophe losses by the type of event
|
||||||||||||||||||||||||||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||||||||||||||||||||||||||
($ in millions) | Number of events | 2023 | Number of events | 2022 | Number of events | 2023 | Number of events | 2022 | ||||||||||||||||||||||||||||||||||||||||||
Hurricanes/tropical storms | 3 | $ | 76 | 1 | $ | 378 | 3 | $ | 76 | 1 | $ | 378 | ||||||||||||||||||||||||||||||||||||||
Tornadoes | — | — | — | — | 3 | 133 | 3 | 148 | ||||||||||||||||||||||||||||||||||||||||||
Wind/hail | 48 | 997 | 32 | 446 | 111 | 5,009 | 78 | 1,712 | ||||||||||||||||||||||||||||||||||||||||||
Wildfires | 2 | 305 | 4 | 19 | 4 | 340 | 8 | 50 | ||||||||||||||||||||||||||||||||||||||||||
Freeze/other events | — | — | — | — | 2 | 4 | 1 | 16 | ||||||||||||||||||||||||||||||||||||||||||
Prior year reserve reestimates | 17 | (4) | 6 | 44 | ||||||||||||||||||||||||||||||||||||||||||||||
Prior year aggregate reinsurance recoveries
|
— | (5) | — | (15) | ||||||||||||||||||||||||||||||||||||||||||||||
Prior quarter reserve reestimates | (214) | (71) | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
Total catastrophe losses | 53 | $ | 1,181 | 37 | $ | 763 | 123 | $ | 5,568 | 91 | $ | 2,333 |
Prior year reserve reestimates
|
||||||||||||||||||||||||||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||||||||||||||||||||||||||
Prior year reserve
reestimates
(1)
|
Effect on
combined ratio
(2)
|
Prior year reserve
reestimates
(1)
|
Effect on
combined ratio
(2)
|
|||||||||||||||||||||||||||||||||||||||||||||||
($ in millions, except ratios) | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||||||||||||||||||
Auto | $ | 33 | $ | 632 | 0.3 | 5.6 | $ | 105 | $ | 1,011 | 0.3 | 3.1 | ||||||||||||||||||||||||||||||||||||||
Homeowners | 62 | 53 | 0.5 | 0.5 | 136 | 181 | 0.4 | 0.6 | ||||||||||||||||||||||||||||||||||||||||||
Other personal lines | (14) | (5) | (0.1) | — | (8) | (14) | — | — | ||||||||||||||||||||||||||||||||||||||||||
Commercial lines | 19 | 64 | 0.1 | 0.6 | 51 | 175 | 0.1 | 0.5 | ||||||||||||||||||||||||||||||||||||||||||
Other business lines | 1 | 2 | — | — | 12 | (4) | — | — | ||||||||||||||||||||||||||||||||||||||||||
Total Allstate Protection | $ | 101 | $ | 746 | 0.8 | 6.7 | $ | 296 | $ | 1,349 | 0.8 | 4.2 | ||||||||||||||||||||||||||||||||||||||
Allstate brand | $ | 7 | $ | 702 | — | 6.3 | $ | (11) | $ | 1,292 | — | 4.0 | ||||||||||||||||||||||||||||||||||||||
National General | 94 | 44 | 0.8 | 0.4 | 307 | 57 | 0.8 | 0.2 | ||||||||||||||||||||||||||||||||||||||||||
Total Allstate Protection | $ | 101 | $ | 746 | 0.8 | 6.7 | $ | 296 | $ | 1,349 | 0.8 | 4.2 |
Impact of specific costs and expenses on the expense ratio
|
||||||||||||||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||||||||||||||
($ in millions, except ratios) | 2023 | 2022 | Change | 2023 | 2022 | Change | ||||||||||||||||||||||||||||||||
Amortization of DAC | $ | 1,533 | $ | 1,414 | $ | 119 | $ | 4,481 | $ | 4,117 | $ | 364 | ||||||||||||||||||||||||||
Advertising expense | 175 | 191 | (16) | 446 | 787 | (341) | ||||||||||||||||||||||||||||||||
Amortization of purchased intangibles | 60 | 61 | (1) | 175 | 178 | (3) | ||||||||||||||||||||||||||||||||
Other costs and expenses, net of other revenue | 764 | 833 | (69) | 2,277 | 2,429 | (152) | ||||||||||||||||||||||||||||||||
Restructuring and related charges | 74 | 14 | 60 | 121 | 24 | 97 | ||||||||||||||||||||||||||||||||
Total underwriting expenses | $ | 2,606 | $ | 2,513 | $ | 93 | $ | 7,500 | $ | 7,535 | $ | (35) | ||||||||||||||||||||||||||
Premiums earned | $ | 12,270 | $ | 11,157 | $ | 1,113 | $ | 35,826 | $ | 32,529 | $ | 3,297 | ||||||||||||||||||||||||||
Expense ratio | ||||||||||||||||||||||||||||||||||||||
Amortization of DAC | 12.5 | 12.7 | (0.2) | 12.5 | 12.7 | (0.2) | ||||||||||||||||||||||||||||||||
Advertising expense | 1.4 | 1.7 | (0.3) | 1.2 | 2.4 | (1.2) | ||||||||||||||||||||||||||||||||
Other costs and expenses | 6.2 | 7.4 | (1.2) | 6.4 | 7.5 | (1.1) | ||||||||||||||||||||||||||||||||
Subtotal | 20.1 | 21.8 | (1.7) | 20.1 | 22.6 | (2.5) | ||||||||||||||||||||||||||||||||
Amortization of purchased intangibles | 0.5 | 0.6 | (0.1) | 0.5 | 0.5 | — | ||||||||||||||||||||||||||||||||
Restructuring and related charges | 0.6 | 0.1 | 0.5 | 0.3 | 0.1 | 0.2 | ||||||||||||||||||||||||||||||||
Total expense ratio | 21.2 | 22.5 | (1.3) | 20.9 | 23.2 | (2.3) |
Underwriting results | ||||||||||||||||||||||||||
($ in millions) | Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Claims and claims expense | ||||||||||||||||||||||||||
Asbestos claims
|
$ | (44) | $ | (34) | $ | (44) | $ | (34) | ||||||||||||||||||
Environmental claims
|
(18) | (56) | (18) | (56) | ||||||||||||||||||||||
Other run-off lines | (20) | (30) | (23) | (34) | ||||||||||||||||||||||
Total claims and claims expense
|
(82) | (120) | (85) | (124) | ||||||||||||||||||||||
Operating costs and expenses | (1) | (2) | (3) | (3) | ||||||||||||||||||||||
Underwriting loss
|
$ | (83) | $ | (122) | $ | (88) | $ | (127) |
Reserves for asbestos, environmental and other run-off claims before and after the effects of reinsurance | ||||||||||||||
($ in millions) | September 30, 2023 | December 31, 2022 | ||||||||||||
Asbestos claims | ||||||||||||||
Gross reserves | $ | 1,204 | $ | 1,190 | ||||||||||
Reinsurance | (378) | (379) | ||||||||||||
Net reserves | 826 | 811 | ||||||||||||
Environmental claims | ||||||||||||||
Gross reserves | 338 | 328 | ||||||||||||
Reinsurance | (66) | (61) | ||||||||||||
Net reserves | 272 | 267 | ||||||||||||
Other run-off claims | ||||||||||||||
Gross reserves | 451 | 437 | ||||||||||||
Reinsurance | (72) | (64) | ||||||||||||
Net reserves | 379 | 373 | ||||||||||||
Total | ||||||||||||||
Gross reserves
|
1,993 | 1,955 | ||||||||||||
Reinsurance | (516) | (504) | ||||||||||||
Net reserves | $ | 1,477 | $ | 1,451 |
Reserves by type of exposure before and after the effects of reinsurance | ||||||||||||||
($ in millions) | September 30, 2023 | December 31, 2022 | ||||||||||||
Direct excess commercial insurance | ||||||||||||||
Gross reserves
|
$ | 1,141 | $ | 1,106 | ||||||||||
Reinsurance | (395) | (385) | ||||||||||||
Net reserves | 746 | 721 | ||||||||||||
Assumed reinsurance coverage | ||||||||||||||
Gross reserves
|
622 | 618 | ||||||||||||
Reinsurance | (58) | (56) | ||||||||||||
Net reserves | 564 | 562 | ||||||||||||
Direct primary commercial insurance | ||||||||||||||
Gross reserves | 144 | 148 | ||||||||||||
Reinsurance | (62) | (62) | ||||||||||||
Net reserves | 82 | 86 | ||||||||||||
Other run-off business | ||||||||||||||
Gross reserves | 1 | 1 | ||||||||||||
Reinsurance | — | — | ||||||||||||
Net reserves | 1 | 1 | ||||||||||||
Unallocated loss adjustment expenses | ||||||||||||||
Gross reserves | 85 | 82 | ||||||||||||
Reinsurance | (1) | (1) | ||||||||||||
Net reserves | 84 | 81 | ||||||||||||
Total | ||||||||||||||
Gross reserves | 1,993 | 1,955 | ||||||||||||
Reinsurance | (516) | (504) | ||||||||||||
Net reserves | $ | 1,477 | $ | 1,451 | ||||||||||
Percentage of gross and ceded reserves by case and IBNR | ||||||||||||||||||||||||||
September 30, 2023 | December 31, 2022 | |||||||||||||||||||||||||
Case | IBNR | Case | IBNR | |||||||||||||||||||||||
Direct excess commercial insurance | ||||||||||||||||||||||||||
Gross reserves
(1)
|
59 | % | 41 | % | 58 | % | 42 | % | ||||||||||||||||||
Ceded
(2)
|
64 | 36 | 63 | 37 | ||||||||||||||||||||||
Assumed reinsurance coverage | ||||||||||||||||||||||||||
Gross reserves
|
33 | 67 | 31 | 69 | ||||||||||||||||||||||
Ceded | 48 | 52 | 33 | 67 | ||||||||||||||||||||||
Direct primary commercial insurance | ||||||||||||||||||||||||||
Gross reserves | 59 | 41 | 57 | 43 | ||||||||||||||||||||||
Ceded | 81 | 19 | 81 | 19 |
Gross payments from case reserves by type of exposure | ||||||||||||||||||||||||||
($ in millions) | Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Direct excess commercial insurance | ||||||||||||||||||||||||||
Gross
(1)
|
$ | 13 | $ | 9 | $ | 45 | $ | 37 | ||||||||||||||||||
Ceded
(2)
|
(7) | (3) | (16) | (13) | ||||||||||||||||||||||
Assumed reinsurance coverage | ||||||||||||||||||||||||||
Gross
|
6 | 14 | 25 | 25 | ||||||||||||||||||||||
Ceded | — | — | (3) | (1) | ||||||||||||||||||||||
Direct primary commercial insurance | ||||||||||||||||||||||||||
Gross
|
1 | 1 | 3 | 4 | ||||||||||||||||||||||
Ceded | — | — | — | (1) | ||||||||||||||||||||||
Summarized financial information
|
||||||||||||||||||||||||||
($ in millions) | Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Premiums written | $ | 658 | $ | 657 | $ | 1,935 | $ | 1,957 | ||||||||||||||||||
Revenues | ||||||||||||||||||||||||||
Premiums | $ | 569 | $ | 504 | $ | 1,656 | $ | 1,475 | ||||||||||||||||||
Other revenue | 75 | 84 | 243 | 269 | ||||||||||||||||||||||
Intersegment insurance premiums and service fees
(1)
|
34 | 39 | 102 | 118 | ||||||||||||||||||||||
Net investment income | 19 | 13 | 53 | 34 | ||||||||||||||||||||||
Costs and expenses | ||||||||||||||||||||||||||
Claims and claims expense | (166) | (141) | (472) | (392) | ||||||||||||||||||||||
Amortization of DAC | (269) | (236) | (779) | (685) | ||||||||||||||||||||||
Operating costs and expenses | (225) | (214) | (664) | (645) | ||||||||||||||||||||||
Restructuring and related charges | (3) | (1) | (4) | (1) | ||||||||||||||||||||||
Income tax expense on operations | (8) | (13) | (34) | (41) | ||||||||||||||||||||||
Less: noncontrolling interest | (1) | — | (1) | 1 | ||||||||||||||||||||||
Adjusted net income | $ | 27 | $ | 35 | $ | 102 | $ | 131 | ||||||||||||||||||
Allstate Protection Plans | $ | 20 | $ | 29 | $ | 79 | $ | 108 | ||||||||||||||||||
Allstate Dealer Services | 5 | 10 | 18 | 27 | ||||||||||||||||||||||
Allstate Roadside | 7 | 1 | 17 | 4 | ||||||||||||||||||||||
Arity | (6) | (2) | (13) | (4) | ||||||||||||||||||||||
Allstate Identity Protection | 1 | (3) | 1 | (4) | ||||||||||||||||||||||
Adjusted net income | $ | 27 | $ | 35 | $ | 102 | $ | 131 | ||||||||||||||||||
Allstate Protection Plans | 140,648 | 134,700 | ||||||||||||||||||||||||
Allstate Dealer Services | 3,813 | 3,888 | ||||||||||||||||||||||||
Allstate Roadside | 554 | 523 | ||||||||||||||||||||||||
Allstate Identity Protection | 2,965 | 2,968 | ||||||||||||||||||||||||
Policies in force as of September 30 (in thousands) | 147,980 | 142,079 |
Summarized financial information
|
||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||
Accident and health insurance premiums and contract charges | $ | 463 | $ | 463 | $ | 1,379 | $ | 1,396 | ||||||||||||||||||
Other revenue | 104 | 90 | 306 | 277 | ||||||||||||||||||||||
Net investment income | 20 | 17 | 60 | 50 | ||||||||||||||||||||||
Costs and expenses | ||||||||||||||||||||||||||
Accident, health and other policy benefits | (262) | (252) | (785) | (785) | ||||||||||||||||||||||
Amortization of DAC | (39) | (33) | (114) | (107) | ||||||||||||||||||||||
Operating costs and expenses | (197) | (207) | (610) | (594) | ||||||||||||||||||||||
Restructuring and related charges | (2) | 1 | (6) | (1) | ||||||||||||||||||||||
Income tax expense on operations | (18) | (16) | (48) | (49) | ||||||||||||||||||||||
Adjusted net income | $ | 69 | $ | 63 | $ | 182 | $ | 187 | ||||||||||||||||||
Benefit ratio
(1)
|
54.9 | 52.7 | 55.1 | 54.4 | ||||||||||||||||||||||
Employer voluntary benefits
(2)
|
3,710 | 3,799 | ||||||||||||||||||||||||
Group health
(3)
|
134 | 116 | ||||||||||||||||||||||||
Individual health
(4)
|
412 | 405 | ||||||||||||||||||||||||
Policies in force as of September 30 (in thousands) | 4,256 | 4,320 |
Premiums and contract charges by line of business
|
||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Employer voluntary benefits | $ | 253 | $ | 257 | $ | 753 | $ | 777 | ||||||||||||||||||
Group health | 111 | 96 | 328 | 285 | ||||||||||||||||||||||
Individual health | 99 | 110 | 298 | 334 | ||||||||||||||||||||||
Premiums and contract charges | $ | 463 | $ | 463 | $ | 1,379 | $ | 1,396 |
Operating costs and expenses
|
||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Non-deferrable commissions | $ | 66 | $ | 77 | $ | 223 | $ | 230 | ||||||||||||||||||
General and administrative expenses | 131 | 130 | 387 | 364 | ||||||||||||||||||||||
Total operating costs and expenses | $ | 197 | $ | 207 | $ | 610 | $ | 594 |
Portfolio composition and strategy by reporting segment
(1)
|
||||||||||||||||||||||||||||||||
September 30, 2023 | ||||||||||||||||||||||||||||||||
($ in millions) | Property-Liability |
Protection Services
|
Allstate Health and Benefits
|
Corporate
and Other |
Total | |||||||||||||||||||||||||||
Fixed income securities
(2)
|
$ | 41,598 | $ | 1,779 | $ | 1,550 | $ | 1,844 | $ | 46,771 | ||||||||||||||||||||||
Equity securities
(3)
|
1,613 | 198 | 44 | 564 | 2,419 | |||||||||||||||||||||||||||
Mortgage loans, net | 703 | — | 127 | — | 830 | |||||||||||||||||||||||||||
Limited partnership interests | 8,349 | — | — | 14 | 8,363 | |||||||||||||||||||||||||||
Short-term investments
(4)
|
2,787 | 132 | 75 | 374 | 3,368 | |||||||||||||||||||||||||||
Other investments, net | 1,486 | — | 122 | — | 1,608 | |||||||||||||||||||||||||||
Total | $ | 56,536 | $ | 2,109 | $ | 1,918 | $ | 2,796 | $ | 63,359 | ||||||||||||||||||||||
Percent to total | 89.3 | % | 3.3 | % | 3.0 | % | 4.4 | % | 100.0 | % | ||||||||||||||||||||||
Market-based | $ | 47,022 | $ | 2,109 | $ | 1,918 | $ | 2,796 | $ | 53,845 | ||||||||||||||||||||||
Performance-based | 9,514 | — | — | — | 9,514 | |||||||||||||||||||||||||||
Total | $ | 56,536 | $ | 2,109 | $ | 1,918 | $ | 2,796 | $ | 63,359 |
Portfolio composition by investment strategy
|
||||||||||||||||||||
September 30, 2023 | ||||||||||||||||||||
($ in millions) |
Market-
based |
Performance-based | Total | |||||||||||||||||
Fixed income securities | $ | 46,675 | $ | 96 | $ | 46,771 | ||||||||||||||
Equity securities | 1,986 | 433 | 2,419 | |||||||||||||||||
Mortgage loans, net | 830 | — | 830 | |||||||||||||||||
Limited partnership interests | 168 | 8,195 | 8,363 | |||||||||||||||||
Short-term investments | 3,368 | — | 3,368 | |||||||||||||||||
Other investments, net | 818 | 790 | 1,608 | |||||||||||||||||
Total | $ | 53,845 | $ | 9,514 | $ | 63,359 | ||||||||||||||
Percent to total | 85.0 | % | 15.0 | % | 100.0 | % | ||||||||||||||
Unrealized net capital gains and losses | ||||||||||||||||||||
Fixed income securities | $ | (3,206) | $ | (2) | $ | (3,208) | ||||||||||||||
Limited partnership interests | — | (1) | (1) | |||||||||||||||||
Short-term investments | (1) | — | (1) | |||||||||||||||||
Other | (2) | — | (2) | |||||||||||||||||
Total | $ | (3,209) | $ | (3) | $ | (3,212) |
Fixed income securities by type
|
||||||||||||||||||||||||||
Fair value as of | ||||||||||||||||||||||||||
($ in millions) | September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||||
U.S. government and agencies | $ | 8,245 | $ | 7,898 | ||||||||||||||||||||||
Municipal | 6,584 | 6,210 | ||||||||||||||||||||||||
Corporate | 29,706 | 26,263 | ||||||||||||||||||||||||
Foreign government | 1,135 | 957 | ||||||||||||||||||||||||
Asset-backed securities (“ABS”) | 1,101 | 1,157 | ||||||||||||||||||||||||
Total fixed income securities | $ | 46,771 | $ | 42,485 |
Fair value and unrealized net capital gains (losses) for fixed income securities by credit rating
|
||||||||||||||||||||||||||||||||||||||
September 30, 2023 | ||||||||||||||||||||||||||||||||||||||
NAIC 1 | NAIC 2 | NAIC 3 | ||||||||||||||||||||||||||||||||||||
A and above | BBB | BB | ||||||||||||||||||||||||||||||||||||
($ in millions) |
Fair
value
|
Unrealized
gain (loss)
|
Fair
value
|
Unrealized
gain (loss)
|
Fair
value
|
Unrealized
gain (loss)
|
||||||||||||||||||||||||||||||||
U.S. government and agencies | $ | 8,245 | $ | (384) | $ | — | $ | — | $ | — | $ | — | ||||||||||||||||||||||||||
Municipal | 6,486 | (451) | 89 | (11) | 7 | 1 | ||||||||||||||||||||||||||||||||
Corporate | ||||||||||||||||||||||||||||||||||||||
Public | 6,665 | (398) | 14,559 | (1,183) | 723 | (74) | ||||||||||||||||||||||||||||||||
Privately placed | 1,846 | (115) | 2,684 | (209) | 1,682 | (155) | ||||||||||||||||||||||||||||||||
Total corporate | 8,511 | (513) | 17,243 | (1,392) | 2,405 | (229) | ||||||||||||||||||||||||||||||||
Foreign government | 1,134 | (61) | 1 | — | — | — | ||||||||||||||||||||||||||||||||
ABS | 1,028 | (9) | 14 | — | 10 | (1) | ||||||||||||||||||||||||||||||||
Total fixed income securities | $ | 25,404 | $ | (1,418) | $ | 17,347 | $ | (1,403) | $ | 2,422 | $ | (229) | ||||||||||||||||||||||||||
NAIC 4 | NAIC 5-6 | Total | ||||||||||||||||||||||||||||||||||||
B | CCC and lower | |||||||||||||||||||||||||||||||||||||
Fair
value
|
Unrealized
gain (loss)
|
Fair
value
|
Unrealized
gain (loss)
|
Fair
value
|
Unrealized
gain (loss)
|
|||||||||||||||||||||||||||||||||
U.S. government and agencies | $ | — | $ | — | $ | — | $ | — | $ | 8,245 | $ | (384) | ||||||||||||||||||||||||||
Municipal | — | — | 2 | 1 | 6,584 | (460) | ||||||||||||||||||||||||||||||||
Corporate | ||||||||||||||||||||||||||||||||||||||
Public | 112 | (7) | — | — | 22,059 | (1,662) | ||||||||||||||||||||||||||||||||
Privately placed | 1,286 | (131) | 149 | (29) | 7,647 | (639) | ||||||||||||||||||||||||||||||||
Total corporate | 1,398 | (138) | 149 | (29) | 29,706 | (2,301) | ||||||||||||||||||||||||||||||||
Foreign government | — | — | — | — | 1,135 | (61) | ||||||||||||||||||||||||||||||||
ABS | — | — | 49 | 8 | 1,101 | (2) | ||||||||||||||||||||||||||||||||
Total fixed income securities | $ | 1,398 | $ | (138) | $ | 200 | $ | (20) | $ | 46,771 | $ | (3,208) |
Unrealized net capital gains (losses)
|
||||||||||||||
September 30, | December 31, | |||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
U.S. government and agencies | $ | (384) | $ | (225) | ||||||||||
Municipal | (460) | (290) | ||||||||||||
Corporate | (2,301) | (2,299) | ||||||||||||
Foreign government | (61) | (40) | ||||||||||||
ABS | (2) | (31) | ||||||||||||
Fixed income securities | (3,208) | (2,885) | ||||||||||||
Short-term investments | (1) | (1) | ||||||||||||
Derivatives | (2) | (3) | ||||||||||||
Equity method of accounting (“EMA”) limited partnerships | (1) | 2 | ||||||||||||
Unrealized net capital gains and losses, pre-tax | $ | (3,212) | $ | (2,887) |
Gross unrealized gains (losses) on fixed income securities by type and sector | ||||||||||||||||||||||||||
($ in millions) |
Amortized
cost, net
|
Gross unrealized |
Fair
value
|
|||||||||||||||||||||||
Gains | Losses | |||||||||||||||||||||||||
September 30, 2023 | ||||||||||||||||||||||||||
Corporate | ||||||||||||||||||||||||||
Banking
(1)
|
$ | 4,228 | $ | 1 | $ | (242) | $ | 3,987 | ||||||||||||||||||
Basic industry | 1,015 | 2 | (74) | 943 | ||||||||||||||||||||||
Capital goods | 2,626 | 1 | (187) | 2,440 | ||||||||||||||||||||||
Communications | 2,773 | — | (262) | 2,511 | ||||||||||||||||||||||
Consumer goods (cyclical and non-cyclical) | 6,909 | 2 | (517) | 6,394 | ||||||||||||||||||||||
Financial services | 2,237 | — | (167) | 2,070 | ||||||||||||||||||||||
Energy | 2,742 | 2 | (155) | 2,589 | ||||||||||||||||||||||
Technology | 2,957 | 4 | (270) | 2,691 | ||||||||||||||||||||||
Transportation | 1,033 | 1 | (73) | 961 | ||||||||||||||||||||||
Utilities | 5,098 | 3 | (318) | 4,783 | ||||||||||||||||||||||
Other | 389 | — | (52) | 337 | ||||||||||||||||||||||
Total corporate fixed income portfolio | 32,007 | 16 | (2,317) | 29,706 | ||||||||||||||||||||||
U.S. government and agencies | 8,629 | 1 | (385) | 8,245 | ||||||||||||||||||||||
Municipal | 7,044 | 3 | (463) | 6,584 | ||||||||||||||||||||||
Foreign government | 1,196 | — | (61) | 1,135 | ||||||||||||||||||||||
ABS | 1,103 | 9 | (11) | 1,101 | ||||||||||||||||||||||
Total fixed income securities | $ | 49,979 | $ | 29 | $ | (3,237) | $ | 46,771 |
December 31, 2022 | ||||||||||||||||||||||||||
Corporate | ||||||||||||||||||||||||||
Banking | $ | 5,153 | $ | 16 | $ | (314) | $ | 4,855 | ||||||||||||||||||
Basic industry | 1,019 | 2 | (75) | 946 | ||||||||||||||||||||||
Capital goods | 2,288 | 3 | (197) | 2,094 | ||||||||||||||||||||||
Communications | 2,422 | 1 | (261) | 2,162 | ||||||||||||||||||||||
Consumer goods (cyclical and non-cyclical) | 5,984 | 6 | (531) | 5,459 | ||||||||||||||||||||||
Financial services | 2,243 | 4 | (176) | 2,071 | ||||||||||||||||||||||
Energy | 2,364 | 2 | (156) | 2,210 | ||||||||||||||||||||||
Technology | 3,137 | 4 | (298) | 2,843 | ||||||||||||||||||||||
Transportation | 959 | 1 | (73) | 887 | ||||||||||||||||||||||
Utilities | 2,633 | 7 | (203) | 2,437 | ||||||||||||||||||||||
Other | 360 | — | (61) | 299 | ||||||||||||||||||||||
Total corporate fixed income portfolio | 28,562 | 46 | (2,345) | 26,263 | ||||||||||||||||||||||
U.S. government and agencies | 8,123 | 6 | (231) | 7,898 | ||||||||||||||||||||||
Municipal | 6,500 | 36 | (326) | 6,210 | ||||||||||||||||||||||
Foreign government | 997 | — | (40) | 957 | ||||||||||||||||||||||
ABS | 1,188 | 4 | (35) | 1,157 | ||||||||||||||||||||||
Total fixed income securities | $ | 45,370 | $ | 92 | $ | (2,977) | $ | 42,485 |
Equity securities by sector | ||||||||||||||||||||||||||||||||||||||
September 30, 2023 | December 31, 2022 | |||||||||||||||||||||||||||||||||||||
($ in millions) | Cost | Over (under) cost |
Fair
value
|
Cost | Over (under) cost |
Fair
value
|
||||||||||||||||||||||||||||||||
Banking | $ | 33 | $ | 35 | $ | 68 | $ | 135 | $ | 56 | $ | 191 | ||||||||||||||||||||||||||
Basic Industry | 11 | 1 | 12 | 57 | 16 | 73 | ||||||||||||||||||||||||||||||||
Capital Goods | 78 | (31) | 47 | 196 | 3 | 199 | ||||||||||||||||||||||||||||||||
Energy | 38 | 3 | 41 | 110 | 44 | 154 | ||||||||||||||||||||||||||||||||
Funds | ||||||||||||||||||||||||||||||||||||||
Equities | 230 | (6) | 224 | 904 | (19) | 885 | ||||||||||||||||||||||||||||||||
Fixed income | 1,364 | (83) | 1,281 | 1,067 | (84) | 983 | ||||||||||||||||||||||||||||||||
Other | 19 | — | 19 | 3 | — | 3 | ||||||||||||||||||||||||||||||||
Total funds | 1,613 | (89) | 1,524 | 1,974 | (103) | 1,871 | ||||||||||||||||||||||||||||||||
Utilities | 56 | — | 56 | 67 | 12 | 79 | ||||||||||||||||||||||||||||||||
Transportation | 18 | 19 | 37 | 48 | 19 | 67 | ||||||||||||||||||||||||||||||||
Other
(1)
|
546 | 88 | 634 | 1,666 | 267 | 1,933 | ||||||||||||||||||||||||||||||||
Total equity securities | $ | 2,393 | $ | 26 | $ | 2,419 | $ | 4,253 | $ | 314 | $ | 4,567 |
Net investment income
|
||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Fixed income securities | $ | 457 | $ | 323 | $ | 1,269 | $ | 889 | ||||||||||||||||||
Equity securities | 15 | 30 | 47 | 100 | ||||||||||||||||||||||
Mortgage loans | 9 | 8 | 25 | 25 | ||||||||||||||||||||||
Limited partnership interests | 190 | 325 | 446 | 841 | ||||||||||||||||||||||
Short-term investments | 59 | 30 | 194 | 42 | ||||||||||||||||||||||
Other investments | 41 | 38 | 121 | 120 | ||||||||||||||||||||||
Investment income, before expense | 771 | 754 | 2,102 | 2,017 | ||||||||||||||||||||||
Investment expense | ||||||||||||||||||||||||||
Investee level expenses | (18) | (17) | (53) | (47) | ||||||||||||||||||||||
Securities lending expense | (25) | (10) | (68) | (13) | ||||||||||||||||||||||
Operating costs and expenses | (39) | (37) | (107) | (111) | ||||||||||||||||||||||
Total investment expense | (82) | (64) | (228) | (171) | ||||||||||||||||||||||
Net investment income | $ | 689 | $ | 690 | $ | 1,874 | $ | 1,846 | ||||||||||||||||||
Property-Liability | $ | 627 | $ | 632 | $ | 1,680 | $ | 1,696 | ||||||||||||||||||
Protection Services | 19 | 13 | 53 | 34 | ||||||||||||||||||||||
Allstate Health and Benefits | 20 | 17 | 60 | 50 | ||||||||||||||||||||||
Corporate and Other | 23 | 28 | 81 | 66 | ||||||||||||||||||||||
Net investment income | $ | 689 | $ | 690 | $ | 1,874 | $ | 1,846 | ||||||||||||||||||
Market-based | $ | 569 | $ | 406 | $ | 1,615 | $ | 1,100 | ||||||||||||||||||
Performance-based | 202 | 348 | 487 | 917 | ||||||||||||||||||||||
Investment income, before expense | $ | 771 | $ | 754 | $ | 2,102 | $ | 2,017 |
Performance-based investment income
|
||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Private equity | $ | 131 | $ | 311 | $ | 348 | $ | 688 | ||||||||||||||||||
Real estate | 71 | 37 | 139 | 229 | ||||||||||||||||||||||
Total performance-based income before investee level expenses | $ | 202 | $ | 348 | $ | 487 | $ | 917 | ||||||||||||||||||
Investee level expenses
(1)
|
(16) | (13) | (48) | (40) | ||||||||||||||||||||||
Total performance-based income | $ | 186 | $ | 335 | $ | 439 | $ | 877 |
Components of net gains (losses) on investments and derivatives and the related tax effect
|
||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Sales | $ | (63) | $ | (175) | $ | (313) | $ | (605) | ||||||||||||||||||
Credit losses | (20) | (6) | (69) | (30) | ||||||||||||||||||||||
Valuation change of equity investments - appreciation (decline): | ||||||||||||||||||||||||||
Equity securities | (14) | (206) | 160 | (1,061) | ||||||||||||||||||||||
Equity fund investments in fixed income securities | (21) | (33) | (7) | (161) | ||||||||||||||||||||||
Limited partnerships
(1)
|
1 | (46) | 34 | (199) | ||||||||||||||||||||||
Total valuation of equity investments | (34) | (285) | 187 | (1,421) | ||||||||||||||||||||||
Valuation change and settlements of derivatives | 31 | 299 | (28) | 889 | ||||||||||||||||||||||
Net gains (losses) on investments and derivatives, pre-tax | (86) | (167) | (223) | (1,167) | ||||||||||||||||||||||
Income tax benefit | 19 | 35 | 48 | 251 | ||||||||||||||||||||||
Net gains (losses) on investments and derivatives, after-tax | $ | (67) | $ | (132) | $ | (175) | $ | (916) | ||||||||||||||||||
Property-Liability | $ | (48) | $ | (98) | $ | (146) | $ | (776) | ||||||||||||||||||
Protection Services | (6) | (10) | (10) | (43) | ||||||||||||||||||||||
Allstate Health and Benefits | (2) | (5) | 1 | (20) | ||||||||||||||||||||||
Corporate and Other | (11) | (19) | (20) | (77) | ||||||||||||||||||||||
Net gains (losses) on investments and derivatives, after-tax | $ | (67) | $ | (132) | $ | (175) | $ | (916) | ||||||||||||||||||
Market-based | $ | (166) | $ | (156) | $ | (293) | $ | (1,238) | ||||||||||||||||||
Performance-based | 80 | (11) | 70 | 71 | ||||||||||||||||||||||
Net gains (losses) on investments and derivatives, pre-tax | $ | (86) | $ | (167) | $ | (223) | $ | (1,167) |
Net gains (losses) on performance-based investments and derivatives
|
||||||||||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Sales | $ | 65 | $ | (10) | $ | 68 | $ | 40 | ||||||||||||||||||
Credit losses | (10) | (3) | (37) | (10) | ||||||||||||||||||||||
Valuation change of equity investments | 8 | (38) | 33 | (43) | ||||||||||||||||||||||
Valuation change and settlements of derivatives | 17 | 40 | 6 | 84 | ||||||||||||||||||||||
Total performance-based | $ | 80 | $ | (11) | $ | 70 | $ | 71 | ||||||||||||||||||
Capital resources | ||||||||||||||
($ in millions) | September 30, 2023 | December 31, 2022 | ||||||||||||
Preferred stock, common stock, treasury stock, retained income and other shareholders’ equity items | $ | 17,163 | $ | 19,880 | ||||||||||
Accumulated other comprehensive loss | (2,570) | (2,392) | ||||||||||||
Total Allstate shareholders’ equity | 14,593 | 17,488 | ||||||||||||
Debt | 7,946 | 7,964 | ||||||||||||
Total capital resources | $ | 22,539 | $ | 25,452 | ||||||||||
Ratio of debt to Allstate shareholders’ equity | 54.5 | % | 45.5 | % | ||||||||||
Ratio of debt to capital resources | 35.3 | 31.3 | ||||||||||||
Debt maturities for each of the next five years
and thereafter (excluding issuance costs and other)
|
||||||||
($ in millions) | ||||||||
2024 | $ | 350 | ||||||
2025 | 600 | |||||||
2026 | 550 | |||||||
2027 | — | |||||||
2028 | — | |||||||
Thereafter | 6,491 | |||||||
Total long-term debt principal | $ | 7,991 |
Intercompany dividends | ||||||||
($ in millions) | ||||||||
AHL to AFIHC | $ | 40 | ||||||
AFIHC to the Corporation | 40 | |||||||
Period |
Total number of shares
(or units) purchased
(1)
|
Average price
paid per share
(or unit)
|
Total number of shares (or units) purchased as part of publicly announced plans or programs
(2)
|
Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs
(3)
|
||||||||||||||||||||||
July 1, 2023 - July 31, 2023 | ||||||||||||||||||||||||||
Open Market Purchases | 214,463 | $ | 107.46 | 212,406 | ||||||||||||||||||||||
August 1, 2023 - August 31, 2023 | ||||||||||||||||||||||||||
Open Market Purchases | 617 | $ | 110.49 | — | ||||||||||||||||||||||
September 1, 2023 - September 30, 2023 | ||||||||||||||||||||||||||
Open Market Purchases | 3,972 | $ | 110.39 | — | ||||||||||||||||||||||
Total | 219,052 | $ | 107.52 | 212,406 | $ | 472 | million |
Incorporated by Reference | ||||||||||||||||||||
Exhibit
Number
|
Exhibit Description | Form |
File
Number
|
Exhibit |
Filing
Date
|
Filed or
Furnished
Herewith
|
||||||||||||||
3.1 | 8-K | 1-11840 | 3(i) | May 23, 2012 | ||||||||||||||||
3.2 | 8-K | 1-11840 | 3.1 | July 17, 2023 | ||||||||||||||||
3.3 | 8-K | 1-11840 | 3.1 | August 5, 2019 | ||||||||||||||||
3.4 | 8-K | 1-11840 | 3.1 | November 8, 2019 | ||||||||||||||||
3.5 | 10-K | 1-11840 | 3.6 | February 21, 2020 | ||||||||||||||||
3.6 | 10-Q | 1-11840 | 3.6 | May 3, 2023 | ||||||||||||||||
3.7 | 8-K | 1-11840 | 3.1 | May 18, 2023 | ||||||||||||||||
4 |
The Allstate Corporation hereby agrees to furnish to the Commission, upon request, the instruments defining the rights of holders of each issue of long-term debt of it and its consolidated subsidiaries
|
|||||||||||||||||||
15 | X | |||||||||||||||||||
31(i) | X | |||||||||||||||||||
31(i) | X | |||||||||||||||||||
32 | X | |||||||||||||||||||
101.INS |
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
X | ||||||||||||||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document | X | ||||||||||||||||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | X | ||||||||||||||||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | X | ||||||||||||||||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | X | ||||||||||||||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | X | ||||||||||||||||||
104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) | X |
|
The Allstate Corporation
|
|||||||
|
(Registrant)
|
|||||||
|
|
|||||||
|
|
|||||||
|
|
|||||||
November 1, 2023 |
By
|
/s/ John C. Pintozzi | ||||||
|
|
John C. Pintozzi | ||||||
|
|
Senior Vice President, Controller and Chief Accounting Officer | ||||||
|
|
(Authorized Signatory and Principal Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|---|---|---|
Regina E. Dugan Recent career Dr. Dugan has served as the President and Chief Executive Officer of Wellcome Leap Inc., a U.S. non-profit organization supporting discovery and innovation for the benefit of human health, since April 2020. Prior to that, Dr. Dugan served as Vice President, Engineering at then-Facebook Inc.’s Building 8 from 2016 to 2018, and Vice President of Engineering at then-Google Inc.’s Advance Technology and Projects from 2012 to 2016. From 2009 to 2012, Dr. Dugan served as the 19th Director of the Defense Advanced Research Projects Agency (“DARPA”), and was the first woman to lead the agency. Prior to that, Dr. Dugan served in various private high tech commercial roles and public roles in the US Department of Defense and the National Aeronautics and Space Administration. Committee membership : Technology HPE director since : 2022 Impact Dr. Dugan’s leadership in both business and government, driving innovation and breakthroughs in advanced technologies, and deep technical experience with technology companies are attributes that we believe meaningfully contribute to our Board’s ability to oversee our technological and strategic transformation. She brings a developer mindset with engineering experience, which offers our Board unique perspectives to better understand emerging technology disciplines, such as cloud computing and AI. Further, as former Director of DARPA and senior executive in global technology companies, Dr. Dugan adds valuable insights on cybersecurity matters and cutting-edge technological research & development to our Board. Skills and qualifications | |||
Raymond J. Lane Recent career Mr. Lane has served as Managing Partner of GreatPoint Ventures, a venture firm focused on early stage enterprise and digital health technologies, since April 2014. Prior to that, Mr. Lane served as executive Chairman of Hewlett-Packard Company from September 2011 to April 2013 and as non-executive Chairman of Hewlett-Packard Company from November 2010 to September 2011. Until December 2019, Mr. Lane served as Managing Partner of Kleiner Perkins, a private equity firm, after having previously served as one of its Managing Partners from 2000 to 2013. Prior to joining Kleiner Perkins, Mr. Lane was President, Chief Operating Officer, and Director of Oracle Corporation, a software company. Before joining Oracle in 1992, Mr. Lane was a senior partner of Booz Allen Hamilton, Inc., a consulting company. Prior to Booz Allen Hamilton, Mr. Lane served as a division vice president with Electronic Data Systems Corporation, an IT services company that Hewlett-Packard Company acquired in August 2008. Mr. Lane served as Chairman of the Board of Trustees of Carnegie Mellon University from July 2009 to July 2015, and currently serves as an Emeritus Trustee. Committee membership : Finance and Investment; Technology HPE director since : 2015 Impact Mr. Lane brings with him a wide variety of corporate experiences: everything from an early stage venture capital investor, principally in the information technology industry, to an executive of a multinational public technology company. Drawing on these experiences from a career leading large technology enterprises spanning several decades, Mr. Lane provides the Board insight into worldwide operations, management, and the development of a winning corporate strategy, which are valuable for navigating HPE’s transformation journey in a quickly changing technology industry. Skills and qualifications | |||
Raymond E. Ozzie Recent career Mr. Ozzie founded and currently serves as the Chief Executive Officer of Blues Wireless Inc., a provider of integrated hardware, software, and services for cellular IoT communications. Mr. Ozzie served as Chief Software Architect and Chief Technical Officer of Microsoft Corporation from 2005 until December 2010, having created Microsoft Azure and having played a key role in Microsoft’s transformation from PC software to being a services-centric company. Mr. Ozzie joined Microsoft in 2005 after it acquired Groove Networks, Inc., a collaboration software company that he founded in 1997. Committee membership : Technology (chair) HPE director since : 2015 Impact As a serial entrepreneur, tech veteran, and the creator of Lotus Notes, Mr. Ozzie is widely recognized as an influential technology expert with a thorough understanding of both business strategy and the software industry. Combined with his experience as an executive in some of the largest multinational technology companies, such as Microsoft, and as an entrepreneur, Mr. Ozzie’s variety of perspectives and seasoned operational leadership have proven invaluable assets to the Board’s ability to identify and execute on a sound business and technological strategy. Skills and qualifications | |||
Patricia F. Russo Recent career Ms. Russo has served as the Chair of our Board of Directors since November 2015. Previously, Ms. Russo served as the Lead Independent Director of Hewlett-Packard Company from July 2014 to November 2015. Ms. Russo served as Chief Executive Officer (“CEO”) of Alcatel-Lucent, S.A., a communications company, from 2006 to 2008. Previously, Ms. Russo served as Chairman of Lucent Technologies Inc. (“Lucent”), a communications company, from 2003 to 2006 and CEO and President of Lucent from 2002 to 2006. Committee membership : Nominating, Governance and Social Responsibility; HR and Compensation HPE director since : 2015 Impact Ms. Russo brings to the Board extensive global business experience along with proven leadership acumen for a wide range of transformative transactions, including mergers and acquisitions and business restructurings, notably having led Lucent through a severe industry downturn and later a merger with Alcatel, as well as overseeing the split of Alcoa Corporation and Arconic Corporation. In addition, Ms. Russo has gained significant experience on governance issues facing large public companies, including from her service as Chair of the Governance and Corporate Responsibility Committee of General Motors Company, and former service as Lead Director and Chair of the Governance and Nominating Committee of Arconic Corporation. A globally recognized thought leader in business and governance, Ms. Russo has led the Board’s oversight and execution of HPE’s transformation journey. Skills and qualifications | |||
Pamela L. Carter Recent career Ms. Carter served as the President of Cummins Distribution Business, a global division of Cummins Inc., a Fortune 500 company focused on diesel and natural gas engine and related technology design, manufacture, and distribution company, from 2008 until her retirement in 2015. Prior to that, Ms. Carter served as Vice President and then President of Cummins Filtration, from 2005 to 2008. From 2000 to 2003, Ms. Carter served as Vice President and General Manager, EMEA at Cummins. Prior to that, Ms. Carter served as Vice President, General Counsel, and Corporate Secretary of Cummins from 1997 to 2000. In 1992, Ms. Carter was elected state attorney general of Indiana, becoming the first African American female to be elected to that office in the United States, serving until 1997. Committee membership : Audit; HR and Compensation (chair) HPE director since : 2015 Impact Ms. Carter brings a wealth of experiences to the HPE Board following a trailblazing career including becoming the first African American woman ever elected as a state attorney general, and subsequently executive officer of Cummins. Ms. Carter also benefits the Board with her comprehensive legal experience in both the public and private sectors, bringing insightful perspective of regulatory and policy knowledge into a business setting. Her experience with issues surrounding global trade, international business strategy and operations, and corporate transformations from her prior leadership of a complex design and manufacturing business are also valuable assets to the Board. Ms. Carter has earned the CERT Certificate in Cybersecurity Oversight developed by NACD, Ridge Global, and Carnegie Mellon University’s CERT division, enhancing her knowledge of cybersecurity risks and oversight, all of which she leverages in Board discussions. Skills and qualifications | |||
Jean M. Hobby Recent career Ms. Hobby served as a Global Strategy Partner at PricewaterhouseCoopers LLP (“PwC”) from 2013 until her retirement in June 2015. Prior to that, Ms. Hobby served as PwC’s Technology, Media and Telecom Sector Leader from 2008 to 2013 and its Chief Financial Officer from 2005 to 2008. Ms. Hobby joined PwC in 1983 and became a partner in 1994. Committee membership : Audit (chair); HR and Compensation HPE director since : 2019 Impact From her senior leadership roles at PwC, including as Global Strategy Partner and CFO, Ms. Hobby brings deep expertise in finance, strategic planning, and technology to the Board. In addition, with her strong experience in audit- and financial control-related matters, she helps drive the Board’s and Audit Committee’s robust exercise of their numerous oversight responsibilities. Skills and qualifications | |||
Gary M. Reiner Recent career Mr. Reiner served as Operating Partner at General Atlantic LLC, a private equity firm, from November 2011 to December 2024. Previously, Mr. Reiner served as Special Advisor to General Atlantic LLC from September 2010 to November 2011. Prior to that, Mr. Reiner served as Senior Vice President and Chief Information Officer at General Electric Company (“GE”), a technology, media and financial services company, from 1996 until March 2010. Mr. Reiner previously held other executive positions with GE since joining the company in 1991. Earlier in his career, Mr. Reiner was a partner at The Boston Consulting Group, Inc., a consulting firm, where he focused on strategic process issues for technology businesses. Committee membership : Nominating, Governance and Social Responsibility (chair); Technology HPE director since : 2015 Impact Mr. Reiner provides decades of experience driving corporate strategy, information technology, and best practices across complex organizations. His prior experience in private equity investing, focused on the IT industry, also enhances the technological expertise represented on our Board and our Technology Committee. HPE’s Board benefits from Mr. Reiner’s deep insight into how IT can help global companies succeed through his many years of experience as Chief Information Officer at General Electric. Skills and qualifications | |||
Frank A. D’Amelio Recent career Mr. D’Amelio served as Executive Vice President and Chief Financial Officer (“CFO”) at Pfizer Inc. (“Pfizer”), a research-based global biopharmaceutical company, from December 2010 until his retirement in May 2022, during which time he had periods of additional responsibility over business operations and global supply chain. Prior to that, Mr. D’Amelio served as Senior Vice President and CFO from 2007 to December 2010 at Pfizer. Before joining Pfizer, Mr. D’Amelio served as Senior Executive Vice President of Business Operations and Integrations of Alcatel-Lucent, a communications company, from December 2006 to August 2007, along with various senior leadership roles at Lucent Technologies, Inc. prior to that, notably as CFO from 2001 to 2005 and as Chief Operating Officer from 2005 to 2006. Committee membership : Audit; Finance and Investment HPE director since : 2023 Impact Mr. D’Amelio contributes valuable insights into financial, operational, strategic, and transformation-related matters, from his in-depth experiences leading and managing large companies in the pharmaceutical and telecommunication technology industries. He exhibits fluency and familiarity with financial statements, public company audit functions, controllership, financial planning and treasury operations, making him a great asset to our Board and both the Audit Committee and Finance and Investment. He also brings seasoned experience helping large global companies navigate global supply chain issues and complex transformations, which we believe will be instrumental for our business resilience efforts and transformation journey. Skills and qualifications | |||
Charles H. Noski Recent career Mr. Noski served as Vice Chairman of Bank of America Corporation from June 2011 until his retirement in September 2012 and as its Chief Financial Officer (“CFO”) from May 2010 to June 2011. Prior to that, Mr. Noski served as CFO of Northrop Grumman Corporation from 2003 until 2005, and as Board Director from 2002 to 2005. Mr. Noski previously served as CFO of AT&T Corporation from 1999 to 2002 and also served as Vice Chairman of the Board of Directors in 2002. From 1990 until 1999, Mr. Noski served in various leadership positions with Hughes Electronics Corporation, including President, Chief Operating Officer, and Board Director. Mr. Noski began his career with Deloitte & Touche LLP in 1973, ultimately serving as partner until 1990. Committee membership : Finance and Investment (chair); Nominating, Governance and Social Responsibility HPE director since : 2020 Impact Mr. Noski brings extensive experience in business operations, risk, finance, accounting, and capital markets to our Board, spanning the aerospace and defense, telecommunications, technology, and financial services sectors. He also exhibits operational and management expertise through his senior leadership roles at large public, global companies. With a combination of business skills and deep expertise in finance and accounting matters, including capital management, restructuring, and capital markets, he is an invaluable asset to help our Board fulfill its various oversight and strategic leadership responsibilities. Skills and qualifications | |||
Bethany J. Mayer Recent career Ms. Mayer served as an Executive Advisor at Siris Capital Group, a private equity firm, from January 2018 to October 2024. She previously served as Executive Vice President, Corporate Development and Technology at Sempra Energy, a public utility company, from November 2018 until January 2019. Prior to that, Ms. Mayer served as President and Chief Executive Officer of Ixia, a leading network testing and security solutions provider where she led the company through a transformative period from 2014 until its acquisition in April 2017 by Keysight Technology Inc. Prior to her time at Ixia, Ms. Mayer was a Senior Vice President, General Manager at Hewlett-Packard Company (“HP”) from 2011 to 2014, leading the expansion of its networking business, and prior to that, a vice president of marketing and alliances for HP’s enterprise servers storage and networking group from 2010 to 2011. Committee membership : Audit; Technology HPE director since : 2023 Impact As a respected technology leader, Ms. Mayer brings broad and diverse expertise in networking, high speed communication, and cybersecurity. Her prior leadership experience in both global corporations and technology startups demonstrates her ability to navigate a dynamic and complex technology landscape while driving business growth. HPE’s Board and our Technology Committee benefit from her strategic mindset, strong leadership skills, and commitment to technological innovation. Ms. Mayer continues to improve her expertise in emerging technologies, as evidenced by her MS in cybersecurity from NYU in 2022 and a graduate certification in AI technology and management from UC Berkeley in 2023. Skills and qualifications | |||
Antonio F. Neri Recent career Mr. Neri has served as President and Chief Executive Officer of Hewlett Packard Enterprise since February 2018. Mr. Neri previously served as President of Hewlett Packard Enterprise from June 2017 to February 2018 and Executive Vice President and General Manager of our Enterprise Group from November 2015 to June 2017. Prior to that, Mr. Neri served in a similar role for Hewlett-Packard Company’s (“HP”) Enterprise Group from October 2014 to November 2015. Mr. Neri served as Senior Vice President and General Manager of the HP Servers business unit from September 2013 to October 2014 and concurrently as Senior Vice President and General Manager of the HP Networking business unit from May 2014 to October 2014. Prior to that, Mr. Neri served as Senior Vice President and General Manager of the HP Technology Services business unit from August 2011 to September 2013 and as Vice President, Customer Services for the HP Personal Systems Group from 2007 to August 2011, having first joined HP in 1996 as a contractor. Committee membership : None HPE director since : 2018 Impact Dedicating more than twenty years to HP and HPE, Mr. Neri rose from serving in a call center for HP Customer Support to our President and CEO. A gifted engineer and inspiring leader, Mr. Neri oversaw the development of numerous technological innovations at HPE, including: HPE Apollo, the industry leading high performance compute platform; HPE Superdome X, the world’s most scalable and modular in-memory computing platform; and HPE Synergy, the world’s first composable infrastructure platform. In addition, Mr. Neri oversaw many of HPE’s strategic acquisitions, including Athonet, Inc., Ampool Inc., Aruba Networks, Inc., Axis Security, Inc., BlueData Software, Inc., Cloud Cruiser, Inc., CloudPhysics, Inc., Cloud Technology Partners, Inc., Cray, Inc., Determined AI, Inc., MapR Technologies, Inc., Morpheus Data LLC, Nimble Storage, Inc., OpsRamp, Inc., Pachyderm, Inc., Silver Peak Systems, Inc., SimpliVity Corporation, Silicon Graphics International Corp., and Zerto, Inc. Mr. Neri is an HPE veteran with a passion for the Company’s customers, partners, employees, and culture. Skills and qualifications | |||
Ann M. Livermore Recent career Ms. Livermore served as Executive Vice President of the Hewlett-Packard Company’s Enterprise Business from 2004 until June 2011, and served as an Executive Advisor to our Chief Executive Officer between then and 2016. Prior to that, Ms. Livermore served in various other positions at Hewlett-Packard Company in marketing, sales, research and development, and business management since joining the Company in 1982. Committee membership : Finance and Investment; Nominating, Governance and Social Responsibility HPE director since : 2015 Impact Ms. Livermore brings extensive operational experience in senior leadership positions from nearly 35 years at Hewlett-Packard Company and Hewlett Packard Enterprise. Her tenure provides the Board vast in-house knowledge and experience in the areas of technology, marketing, sales, research and development, and business management, as well as provides senior management with insightful leadership. Skills and qualifications |
Name and
principal position
|
Year |
Salary
($)
|
Bonus
($) |
Stock
awards
($)
|
Option
awards ($) |
Non-equity
incentive plan
compensation
($)
|
Change
in pension
value and
nonqualified
deferred
compensation
earnings
($)
|
All other compensation
($)
|
Total
($) |
||||||||||||||||||||
Antonio F. Neri
President and Chief Executive Officer
|
2024
|
1,300,000 | — | 17,646,855 | — | 2,350,318 | 35,225 | 78,799 | 21,411,197 | ||||||||||||||||||||
2023 | 1,300,000 | — | 15,577,803 | — | 3,053,361 | — | 135,385 | 20,066,549 | |||||||||||||||||||||
2022 | 1,275,000 | — | 13,386,710 | — | 2,352,980 | — | 351,675 | 17,366,365 | |||||||||||||||||||||
Marie E. Myers
Executive Vice President, Chief Financial Officer
|
2024
|
676,136 | 500,000 | 11,137,583 | — | 916,809 | — | 12,255 | 13,242,783 | ||||||||||||||||||||
John F. Schultz
Executive Vice President,
Chief Operating and Legal Officer
|
2024
|
800,000 | — | 7,504,666 | — | 1,039,564 | — | 104,000 | 9,448,230 | ||||||||||||||||||||
2023 | 800,000 | — | 6,750,387 | — | 1,476,350 | — | 94,429 | 9,121,166 | |||||||||||||||||||||
2022 | 800,000 | — | 6,052,518 | — | 971,605 | — | 112,491 | 7,936,614 | |||||||||||||||||||||
Fidelma M. Russo
Executive Vice President, General Manager of Hybrid Cloud and Chief Technology Officer
|
2024
|
750,000 | — | 6,051,172 | — | 306,892 | — | 152,481 | 7,260,545 | ||||||||||||||||||||
Neil B. MacDonald
Executive Vice President,
General Manager of Server
|
2024
|
600,000 | — | 5,391,201 | — | 1,442,063 | — | 71,115 | 7,504,379 | ||||||||||||||||||||
2023 | 550,000 | — | 4,673,358 | — | 624,999 | — | 166,016 | 6,014,373 | |||||||||||||||||||||
2022 | 550,000 | — | 3,089,231 | — | 1,012,761 | — | 33,443 | 4,685,435 | |||||||||||||||||||||
Jeremy Cox
Senior Vice President, Corporate Controller and Chief Tax Officer & Former Interim Chief Financial Officer
|
2024
|
650,000 | — | 3,500,007 | — | 461,956 | — | 32,000 | 4,643,963 | ||||||||||||||||||||
2023 | 650,000 | — | 999,994 | — | 850,579 | — | 34,750 | 2,535,323 |
Customers
Customer name | Ticker |
---|---|
Aon Plc | AON |
Marsh & McLennan Companies, Inc. | MMC |
Unum Group | UNM |
Suppliers
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|---|---|---|
Neri Antonio F | - | 1,508,640 | 0 |
Lane Raymond J. | - | 955,384 | 0 |
SCHULTZ JOHN F | - | 278,118 | 0 |
MacDonald Neil B | - | 140,036 | 0 |
Carter Pamela L | - | 103,347 | 39,541 |
Gold Gerri | - | 76,839 | 0 |
Cox Jeremy | - | 68,590 | 0 |
RUSSO FIDELMA | - | 55,908 | 0 |
Hobby Jean M. | - | 46,161 | 0 |
Mottram Phil | - | 35,107 | 0 |
MacDonald Neil B | - | 28,197 | 0 |
Mottram Phil | - | 26,466 | 0 |
REINER GARY M | - | 16,481 | 105,738 |
RUSSO PATRICIA F | - | 15,318 | 272,479 |
Domenech Daniel P | - | 15,025 | 0 |
Cox Jeremy | - | 14,374 | 0 |
Hotard Justin | - | 14,162 | 0 |
DUGAN REGINA E | - | 9,637 | 0 |
Cox Jeremy | - | 615 | 0 |
Mayer Bethany | - | 0 | 20,078 |